rfhg_201570.1

Basic information about the TSS

---

TSS ID: rfhg_201570.1 Species: human Chr: chr18		Start: 12377189 End: 12377199 Strand: -
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: Y18314:0 BC065016:0 GeneID: 10939 HGNC/MGI_ID: HGNC:315 UniProt_ID: Nearer transcript ids and distances: ENST00000269143.8:-28 NM_006796.3:-28 BC024282:-57 ENST00000590811.1:187 view more...

Gene_name: AFG3 like matrix AAA peptidase subunit 2 Gene_symbol: AFG3L2 Gene_synonyms: SPAX5 Gene_source: HGNC:315

TATA-Box annotation

---

Distance to TSS:	82
Nearest PromoterID:	NM_006796
Entrez ID:	10939
Nearest Unigene:	Hs.726355
Nearest Refseq:	NM_006796
Nearest Ensembl:	ENSG00000141385
Gene Name:	AFG3 like matrix AAA peptidase subunit 2
Gene Alias:	SCA28|SPAX5
Gene Type:	protein-coding
CpG%:	0.300000
GC%:	0.818182
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@AFG3L2 p2@AFG3L2 p3@AFG3L2 p4@AFG3L2 p5@AFG3L2 p6@AFG3L2
Sample		p1@AFG3L2	p2@AFG3L2	p3@AFG3L2	p4@AFG3L2	p5@AFG3L2	p6@AFG3L2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	43.83	0.58	2.14	2.92	1.56	4.09
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	53.01	1.82	4.25	2.83	1.82	3.84
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	39.74	1.35	1.93	1.74	1.16	3.28
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	46.99	1.66	3.33	2.91	1.25	4.57
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	49.04	0.90	4.27	2.70	1.35	5.17
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	35.08	0.78	3.49	1.36	1.16	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	52.95	2.61	1.96	4.58	1.74	5.45
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	44.33	0.73	2.91	4.12	2.18	6.06
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	54.28	1.28	4.06	3.63	2.14	5.77
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	70.71	4.64	8.69	4.64	5.80	8.69
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	62.66	3.23	10.51	2.43	5.66	11.32
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	71.55	2.85	7.32	6.50	2.85	12.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	54.00	5.80	2.58	1.45	1.93	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	38.79	4.96	0.90	1.20	1.65	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	49.18	5.05	0.66	0.88	1.76	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	54.32	3.27	1.01	1.51	1.26	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	44.34	5.90	0.66	2.84	1.53	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	35.01	3.37	0.84	1.69	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	40.52	2.67	1.60	0.53	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	48.14	4.51	1.50	1.20	0.75	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	48.25	4.81	1.47	1.34	1.20	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	41.26	4.83	1.21	1.55	2.76	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	44.08	5.30	1.42	1.81	1.29	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	51.20	6.31	1.21	1.70	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	57.53	5.93	4.13	3.10	1.03	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	55.07	6.96	3.48	2.53	1.27	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	44.51	4.95	1.65	0.00	1.65	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	53.28	3.54	2.59	2.36	3.54	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	39.57	5.65	2.75	1.62	2.42	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	47.23	4.52	1.81	2.17	2.35	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	46.26	6.28	3.35	2.72	1.05	1.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	53.53	4.88	3.52	1.56	2.74	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	41.99	4.85	0.84	2.11	2.32	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	24.58	2.80	1.32	0.82	1.15	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	57.97	3.55	2.99	1.87	2.43	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	51.74	6.13	4.02	2.87	3.07	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	50.48	6.95	1.84	2.45	2.04	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	46.14	6.04	4.43	1.61	2.01	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	55.91	4.59	2.70	3.24	1.62	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	53.29	8.16	2.64	2.40	1.20	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	44.70	6.35	2.82	1.41	2.82	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	27.81	3.37	1.32	1.32	0.59	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	49.35	9.49	5.06	3.16	1.48	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	44.58	6.47	3.32	1.05	1.75	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	50.39	8.43	4.42	1.81	2.61	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	42.81	7.44	3.02	2.09	0.47	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	50.86	6.96	4.32	1.68	1.44	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	43.52	5.96	2.38	3.58	2.09	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	43.57	9.57	1.68	1.68	1.20	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	34.17	5.46	1.01	0.40	1.01	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	35.87	4.10	1.64	1.23	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	43.14	6.23	1.11	1.56	1.11	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	27.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	41.16	7.45	2.48	0.71	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	42.09	11.93	2.32	2.32	2.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	0.84	0.84	1.68	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	12.40	2.76	0.92	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	58.02	10.05	2.59	1.62	2.92	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	48.50	6.74	4.18	1.93	2.89	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	18.55	3.77	0.31	0.31	1.57	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	43.01	9.17	1.41	2.12	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	42.62	7.85	1.12	1.12	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	8.76	1.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	17.33	3.06	1.36	0.00	0.68	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	60.44	4.87	1.95	2.60	2.27	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	51.12	6.39	1.77	2.13	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	28.76	6.34	0.00	0.49	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	44.13	3.97	0.50	0.99	1.98	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	34.71	4.69	0.47	0.47	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	30.47	0.99	0.33	0.33	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	51.66	5.26	1.86	1.24	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	53.81	4.89	1.83	1.22	0.92	0.31
Adipocyte - breast, donor1	11376-118A8	26.29	0.32	0.16	0.63	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	31.76	3.53	1.93	2.57	0.48	4.65
Adipocyte - omental, donor1	11473-119C6	31.30	2.29	1.02	1.78	0.51	1.40
Adipocyte - omental, donor2	11474-119C7	18.69	2.99	0.00	0.75	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	29.47	4.02	1.34	3.01	0.67	1.34
Adipocyte - perirenal, donor1	11476-119C9	18.50	2.55	0.00	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	4.40	0.00	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	22.58	1.35	0.00	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	29.19	2.43	0.52	0.35	1.91	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	48.11	2.74	0.20	1.76	0.59	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	25.48	3.09	0.77	0.77	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	29.55	4.18	0.84	1.67	1.12	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	40.56	4.11	1.18	1.18	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	72.31	5.31	3.86	5.23	1.13	3.06
Adipocyte differentiation, day08, donor2	13023-139D8	33.89	3.23	0.65	1.94	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	33.59	2.67	1.60	0.00	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	50.64	5.01	3.90	2.78	2.23	2.78
Adipocyte differentiation, day12, donor1	13021-139D6	62.38	11.64	6.24	2.50	2.08	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	32.65	5.27	1.76	2.51	1.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	38.94	3.93	2.62	2.95	1.31	2.62
Adipocyte differentiation, day12, donor4	13030-139E6	53.89	6.39	3.96	1.83	2.13	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	24.09	1.99	0.22	0.88	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	8.96	0.72	0.00	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	33.82	1.08	0.18	1.26	0.18	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	26.78	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	22.60	2.88	0.41	0.62	1.03	0.41
Anulus Pulposus Cell, donor1	11248-116E6	18.19	2.29	0.11	0.23	0.69	0.23
Anulus Pulposus Cell, donor2	11463-119B5	17.39	3.92	0.98	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.54	2.25	1.35	0.00	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.55	3.47	0.43	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.36	2.39	0.30	0.00	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	0.00	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.84	1.32	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.72	0.97	0.32	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.71	2.43	1.46	0.00	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.28	1.19	0.59	0.00	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.43	0.38	0.00	0.00	0.38	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.26	1.45	1.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	2.51	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	16.14	2.14	0.33	0.49	0.66	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	4.09	1.36	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	23.37	1.51	1.06	0.30	0.45	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.00	1.61	1.07	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.06	2.08	0.94	0.57	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.90	3.74	0.27	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	1.95	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.26	1.99	1.16	0.33	0.33	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	1.20	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	12.86	3.09	0.51	0.51	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	13.11	0.97	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.38	1.14	0.76	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	1.21	3.63	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	1.71	0.57	0.57	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.46	1.71	0.64	0.21	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	14.97	1.81	0.26	0.77	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.01	0.94	0.94	0.00	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	13.18	2.57	0.00	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	2.14	1.43	1.43	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	1.17	0.00	0.00	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.45	2.71	0.90	0.00	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	2.38	0.00	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	12.71	0.51	0.51	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	15.54	1.53	0.76	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	0.64	0.64	0.64	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.51	1.29	0.00	0.00	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	14.61	2.12	0.42	0.42	0.00	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.95	1.74	0.58	0.29	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.41	2.03	0.17	0.85	0.51	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	2.11	0.00	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.79	1.93	0.21	0.00	0.43	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	11.43	1.20	0.60	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.75	0.73	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.02	2.76	1.15	0.23	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	7.65	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	26.69	1.53	1.02	1.02	1.02	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.93	1.24	1.03	0.00	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.30	1.22	0.92	0.61	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.56	1.43	0.96	0.00	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.63	0.67	0.22	0.89	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	3.05	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	2.22	0.00	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	13.24	1.85	1.32	0.53	0.79	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.36	2.54	0.73	0.00	0.36	0.73
Astrocyte - cerebellum, donor1	11500-119F6	28.86	2.33	0.74	1.35	0.61	0.74
Astrocyte - cerebellum, donor2	11580-120F5	28.93	1.20	1.03	1.20	0.86	0.34
Astrocyte - cerebellum, donor3	11661-122F5	17.20	1.89	0.00	1.26	0.84	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	31.37	3.83	1.05	0.70	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	33.81	5.01	0.32	0.32	2.10	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	35.20	3.88	0.60	0.75	1.19	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	54.70	10.09	3.44	2.06	3.90	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	63.89	12.78	2.51	2.76	3.63	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	56.90	11.95	2.73	3.07	3.30	1.71
Basophils, donor1	12241-129G9	19.09	2.88	1.57	0.26	0.26	0.00
Basophils, donor2	12242-129H1	39.69	4.33	4.33	0.72	0.36	0.00
Basophils, donor3	12243-129H2	32.19	3.23	1.47	1.03	0.15	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	19.40	1.51	1.29	0.43	0.00	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	13.72	1.37	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	25.73	0.63	1.88	1.26	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	30.36	3.95	0.83	2.70	2.08	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	31.32	6.22	0.46	0.92	1.84	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	27.35	1.98	0.00	0.54	0.54	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	63.28	8.66	4.33	3.30	7.11	2.47
Burkitt's lymphoma cell line:RAJI	10476-106I8	132.29	13.04	4.43	4.43	4.89	1.86
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	68.75	4.48	2.56	1.60	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	44.52	9.58	1.69	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	34.52	8.91	2.04	0.19	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	30.30	8.56	2.85	0.88	0.44	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	32.55	4.81	2.55	1.13	1.13	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	44.73	7.58	1.90	1.90	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	48.65	7.56	0.66	2.30	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	20.67	6.22	3.04	1.01	1.01	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	21.73	5.13	4.53	1.21	1.51	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	24.40	6.16	3.08	0.95	0.95	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	17.58	5.36	2.34	0.67	0.50	1.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.08	3.31	4.97	0.83	2.48	2.21
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	17.36	2.98	3.47	0.99	0.74	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	12.92	3.52	2.15	0.39	0.20	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	15.85	3.38	3.56	1.07	0.89	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	18.50	3.92	5.01	1.52	0.22	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	13.81	1.40	3.28	0.94	0.00	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	19.01	6.34	4.22	1.58	1.06	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	17.75	2.22	2.22	3.33	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	13.54	4.61	2.53	0.74	0.59	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	20.55	4.99	3.39	1.60	0.60	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	16.03	4.79	3.33	3.12	0.62	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	18.76	3.89	2.97	1.83	0.23	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	15.38	3.17	2.94	1.36	1.58	1.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.04	3.49	3.49	1.31	1.31	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	17.22	7.53	3.50	1.08	0.81	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	18.32	7.50	4.88	2.62	1.40	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	19.78	3.79	4.21	1.68	0.00	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.66	3.12	2.39	0.55	0.18	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	14.80	1.76	3.87	0.35	1.06	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	9.21	4.83	2.19	0.88	1.32	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.08	4.36	1.92	0.35	0.35	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	16.73	2.97	1.86	2.60	0.74	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.24	5.17	1.29	0.65	1.08	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	13.92	6.55	0.82	0.82	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.52	2.55	1.85	0.93	0.46	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	13.46	3.48	3.48	1.62	0.00	2.09
CD14+CD16+ Monocytes, donor1	11789-124B7	29.21	6.54	2.18	1.96	1.09	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	25.41	5.54	1.62	0.69	0.23	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	32.06	6.07	1.73	1.52	0.87	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	32.23	7.16	3.27	0.31	1.25	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	27.77	6.29	1.40	0.52	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	35.68	7.36	4.01	0.67	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	31.90	9.44	2.04	1.28	1.28	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	27.01	5.27	2.20	0.44	0.22	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	34.74	6.32	3.58	1.05	0.42	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	2.03	4.06	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	37.97	1.36	0.68	1.36	2.03	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	38.32	2.07	2.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	34.65	2.13	0.00	1.07	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	41.81	2.68	2.14	0.00	2.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	47.73	4.21	0.00	0.70	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	31.37	5.49	0.00	0.00	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	47.46	5.27	2.64	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	55.89	14.79	7.40	4.11	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	43.53	17.41	8.71	0.73	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	45.43	14.64	5.05	3.03	1.51	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	76.37	2.42	1.21	2.83	1.21	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	83.49	0.40	0.40	3.20	0.40	2.00
CD34+ Progenitors, donor1	11545-120B6	31.13	3.01	1.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	46.63	6.18	3.37	1.12	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	55.61	7.14	1.88	1.50	1.50	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	48.93	6.09	0.90	0.45	1.13	0.45
CD4+ T Cells, donor1	11225-116C1	68.55	6.07	1.79	1.07	2.86	0.00
CD4+ T Cells, donor2	11306-117C1	59.40	7.96	3.67	1.84	3.67	0.00
CD4+ T Cells, donor3	11382-118B5	46.36	8.23	4.57	1.83	1.22	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	38.29	1.28	2.04	1.79	0.51	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	65.36	3.37	0.67	1.80	2.25	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	45.99	4.02	0.29	2.59	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	76.33	3.79	1.42	1.90	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	75.15	4.92	0.70	3.51	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	72.52	0.00	3.30	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	24.57	4.05	1.73	0.87	1.01	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	41.52	4.58	1.19	2.03	1.19	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	33.53	3.71	0.81	2.26	0.81	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	41.24	5.83	1.34	0.90	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	37.73	2.80	1.05	1.75	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	33.44	3.08	1.32	0.88	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.06	2.53	0.42	0.42	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	50.07	5.61	1.04	2.08	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	49.45	5.35	2.34	2.34	2.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	68.53	3.81	2.72	2.45	0.82	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	82.00	3.75	2.14	3.75	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	64.56	3.59	0.00	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	38.20	3.34	1.30	1.85	1.11	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	50.04	2.38	1.52	2.38	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	40.98	2.10	0.84	1.89	1.47	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	46.52	4.04	2.53	0.51	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	55.02	7.37	2.60	1.30	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.94	3.05	1.74	0.87	1.31	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	57.40	4.45	0.99	0.00	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	41.54	3.69	0.92	1.85	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	57.23	2.79	1.40	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	41.54	5.54	1.66	0.55	2.49	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	44.17	4.17	1.72	0.74	1.47	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	40.04	3.08	1.54	3.08	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	45.48	7.16	0.72	1.07	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	41.55	1.38	0.00	4.15	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	61.88	6.22	0.98	1.64	0.98	0.65
CD8+ T Cells, donor2	11307-117C2	51.81	9.01	2.25	0.75	3.00	0.38
CD8+ T Cells, donor3	11383-118B6	75.24	7.57	1.77	2.02	1.26	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	50.92	4.36	2.52	2.75	2.29	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	41.94	5.27	1.68	1.92	1.68	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	38.03	3.01	1.09	1.64	2.19	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	25.52	1.80	1.20	0.90	0.90	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	38.88	3.12	2.88	3.12	2.16	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	47.52	2.27	4.55	0.91	1.82	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	51.93	6.30	4.56	2.82	1.30	1.74
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	46.06	5.26	6.32	3.16	5.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	41.98	3.05	2.81	0.94	2.35	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	42.26	4.23	2.72	3.32	1.21	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	37.77	5.81	4.94	1.45	2.61	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	45.56	6.66	4.26	2.66	2.40	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	35.90	2.19	1.75	1.75	4.38	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	32.34	6.38	5.92	3.19	1.82	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.77	4.48	4.48	4.48	3.73	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	54.38	3.24	3.60	1.08	2.16	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	39.99	5.18	4.89	3.74	2.01	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	48.79	4.71	2.83	1.18	0.71	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	35.49	3.80	3.80	2.22	2.54	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	47.06	8.00	5.54	3.08	3.08	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	40.71	5.13	4.49	2.24	2.89	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	40.16	5.74	7.27	1.15	1.53	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	46.90	6.70	5.12	2.76	3.55	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	40.09	3.03	3.03	2.27	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	6.42	2.41	3.21	3.21	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	37.07	2.80	5.60	4.20	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	28.05	1.00	5.01	4.01	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	29.24	14.62	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	11.86	2.47	0.49	0.99	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	25.78	2.10	0.11	0.63	0.21	0.21
Chondrocyte - de diff, donor1	11261-116G1	34.67	3.81	1.04	1.04	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	18.48	2.84	0.36	0.00	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	16.61	3.30	0.57	0.23	1.14	0.57
Chondrocyte - re diff, donor2	11339-117F7	25.96	3.58	2.69	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	22.65	4.45	1.21	0.40	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	34.54	2.98	1.03	0.11	0.34	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	28.43	3.63	0.64	0.00	0.86	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	26.64	3.27	0.44	0.44	0.53	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	38.88	6.14	1.28	0.64	0.55	0.92
Corneal Epithelial Cells, donor1	11526-119I5	12.95	0.66	0.00	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	21.61	2.28	0.00	0.00	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	26.59	2.05	0.26	1.28	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	49.03	5.28	2.48	1.49	0.66	0.66
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	44.47	6.62	4.10	2.84	0.95	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	17.25	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	29.81	6.80	3.02	1.40	0.43	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	42.02	5.12	2.05	1.02	1.02	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	30.68	3.92	1.31	0.65	2.61	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	30.49	8.23	1.94	0.97	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	22.85	3.00	0.67	1.33	0.67	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	17.60	2.35	1.17	0.59	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	26.30	3.11	0.85	1.70	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	22.80	3.93	0.39	0.00	0.79	0.39
Endothelial Cells - Artery, donor1	11264-116G4	28.21	3.49	0.58	1.16	0.87	0.58
Endothelial Cells - Artery, donor2	11341-117F9	27.29	3.76	0.94	0.47	0.47	0.71
Endothelial Cells - Artery, donor3	11413-118E9	21.39	2.28	0.70	0.70	0.53	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	26.60	4.21	0.22	1.33	0.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.47	1.83	0.61	1.52	0.61	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	26.50	3.10	0.56	0.56	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	15.15	1.19	0.30	0.89	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	21.35	5.73	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	12.34	2.27	0.00	0.14	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	40.01	2.80	2.00	2.00	1.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	15.20	2.62	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	45.23	3.85	0.99	0.87	0.87	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	45.84	4.13	1.52	1.52	1.09	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	43.60	4.76	2.08	1.34	0.98	0.24
Endothelial Cells - Vein, donor1	11267-116G7	22.75	2.28	0.00	0.00	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	21.65	1.40	0.00	0.00	2.10	0.70
Endothelial Cells - Vein, donor3	11416-118F3	25.28	4.71	0.94	1.10	0.94	0.47
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	36.31	1.65	3.30	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	24.97	0.00	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	19.06	0.73	0.73	0.24	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	32.84	3.69	0.41	0.41	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.58	1.42	0.22	0.55	1.20	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	23.73	2.49	0.87	0.11	0.87	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.56	2.18	0.61	0.85	0.12	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	30.98	1.09	0.27	1.36	0.00	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.83	2.53	0.42	0.11	0.21	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	28.98	1.32	0.79	1.05	0.00	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	25.25	3.99	1.66	0.66	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	24.95	2.27	0.45	0.91	0.00	1.81
Fibroblast - Cardiac, donor2	11345-117G4	34.87	2.27	0.00	0.00	1.52	0.76
Fibroblast - Cardiac, donor3	11417-118F4	16.09	2.68	0.47	1.10	0.63	0.63
Fibroblast - Cardiac, donor4	11452-119A3	40.92	4.55	0.91	1.21	0.61	0.91
Fibroblast - Cardiac, donor5	11456-119A7	30.71	3.55	0.63	0.63	0.89	0.25
Fibroblast - Cardiac, donor6	11460-119B2	32.44	4.55	0.15	1.06	0.45	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	31.09	2.28	0.27	0.94	0.27	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.59	5.18	0.43	0.43	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	0.00	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	41.52	4.15	0.92	1.85	2.08	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	25.95	4.92	0.68	0.51	1.53	0.17
Fibroblast - Dermal, donor1	11269-116G9	30.76	2.58	0.70	1.17	0.94	0.00
Fibroblast - Dermal, donor2	11346-117G5	29.24	1.89	0.00	1.42	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	25.99	2.78	0.36	0.24	0.97	0.24
Fibroblast - Dermal, donor4	11450-119A1	46.69	3.84	1.81	0.90	1.02	0.68
Fibroblast - Dermal, donor5	11454-119A5	47.63	5.06	0.70	1.40	0.35	0.70
Fibroblast - Dermal, donor6	11458-119A9	54.25	5.04	1.30	1.14	0.81	0.97
Fibroblast - Gingival, donor1	11237-116D4	27.28	3.96	1.04	0.42	0.62	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	28.30	3.67	1.05	0.79	1.05	0.26
Fibroblast - Gingival, donor2	11318-117D4	27.02	3.95	0.79	0.79	0.53	0.40
Fibroblast - Gingival, donor3	11394-118C8	29.30	4.45	0.58	0.10	1.26	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	20.78	1.04	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	16.21	2.11	0.18	0.53	0.35	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	40.38	3.90	0.78	1.25	0.62	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	20.01	3.52	0.81	0.68	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	28.23	2.12	0.35	0.71	0.35	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	37.88	2.78	1.17	0.44	1.02	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	24.00	3.41	0.82	0.82	0.41	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	47.17	2.85	1.32	1.86	0.88	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	21.86	2.64	0.44	0.44	0.59	0.29
Fibroblast - Lung, donor1	11270-116H1	16.31	0.00	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	1.49	1.49	0.00	1.49	2.98
Fibroblast - Lung, donor3	11419-118F6	32.71	4.85	0.42	1.06	0.21	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	29.16	0.83	0.83	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	6.16	0.00	0.28	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	45.87	3.25	2.03	0.41	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	15.98	7.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	28.32	4.66	1.36	0.39	0.78	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	43.68	5.16	0.46	1.67	1.37	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	41.00	2.45	0.00	1.22	0.00	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	24.04	3.05	0.76	1.14	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.28	3.51	0.27	0.54	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	22.73	3.48	0.58	0.70	0.81	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	22.00	2.21	0.66	0.77	0.77	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	35.15	2.03	1.02	1.02	0.41	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	24.06	2.67	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	23.72	3.16	0.40	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	29.57	1.19	0.60	0.79	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.23	1.24	0.18	0.36	0.53	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	26.80	3.15	0.39	0.99	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.68	1.81	0.30	1.20	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	18.03	1.62	0.76	0.43	0.76	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	22.27	1.77	0.00	0.51	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	18.54	2.13	0.00	0.33	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	39.10	2.21	0.20	1.40	0.40	1.00
Fibroblast - skin normal, donor2	11561-120D4	19.79	1.31	0.60	1.21	0.90	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	27.50	4.23	1.21	1.21	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	22.20	2.07	0.25	0.33	0.50	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	18.46	1.88	0.34	0.34	0.85	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	23.32	1.31	0.99	0.66	0.00	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.71	1.92	0.32	0.85	0.43	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	21.25	1.86	0.67	0.84	0.67	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.12	1.73	0.16	0.00	0.31	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	54.91	8.72	2.61	0.00	2.61	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	27.56	2.95	1.04	0.52	0.35	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	29.67	3.12	0.26	0.52	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	34.24	2.56	0.51	1.79	0.77	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	68.13	2.30	2.30	3.83	3.06	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	77.21	2.55	3.83	5.10	1.28	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	130.94	3.14	2.28	3.14	3.14	5.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	46.05	3.03	0.00	0.28	0.55	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	46.35	3.20	1.37	0.68	2.28	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	112.93	2.38	1.39	2.18	3.17	3.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	43.62	3.44	0.53	0.79	0.26	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	54.79	5.54	1.63	2.61	0.33	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	103.48	3.10	1.77	3.10	1.33	3.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	57.94	4.10	1.13	1.55	1.27	3.82
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	47.29	4.68	1.11	1.35	1.35	1.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	54.80	2.42	0.81	2.15	1.88	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	32.09	2.23	1.36	0.25	1.12	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	33.08	1.94	1.52	0.42	1.52	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	37.41	2.24	0.41	1.22	1.83	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	29.21	3.42	0.91	0.91	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	26.53	4.11	0.62	0.37	0.75	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	36.50	0.66	0.87	0.00	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	36.05	2.66	1.18	1.18	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	32.59	3.66	1.59	0.79	1.11	1.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	39.99	3.35	1.12	1.56	0.45	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	33.47	5.44	1.61	0.60	0.40	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	29.86	4.92	1.02	1.70	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	42.56	3.01	0.80	1.68	1.06	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	34.55	4.27	1.87	1.46	1.25	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.81	3.24	1.37	0.51	0.85	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	39.06	6.86	3.10	1.77	1.11	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.61	4.33	1.41	1.25	1.41	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.89	2.65	1.43	1.02	0.41	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	27.85	6.19	2.06	1.24	1.44	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	31.36	7.38	1.84	1.15	1.15	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	38.86	5.00	1.83	0.83	2.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	33.29	5.29	1.76	0.66	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	37.76	6.64	2.71	2.46	1.97	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.39	4.21	3.24	1.95	1.95	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	42.98	6.41	1.60	1.92	1.60	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	31.36	5.59	2.75	0.66	1.04	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	37.17	3.95	2.06	2.21	1.74	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	45.00	6.69	3.04	0.91	1.22	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.38	6.69	1.36	0.94	1.36	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	38.20	5.05	3.29	2.20	2.20	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.00	5.05	2.81	0.84	0.84	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	36.94	6.94	3.15	1.39	1.67	1.39
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	48.13	8.56	3.21	2.94	0.80	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	42.84	3.98	1.68	3.37	2.60	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	37.31	6.48	2.98	2.07	1.42	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	46.08	11.93	4.61	5.15	4.61	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	35.58	5.16	1.47	2.40	1.47	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.63	5.26	1.32	1.10	2.41	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	49.59	6.94	0.99	2.98	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	21.37	3.69	0.92	1.06	0.79	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.40	4.04	1.41	0.81	0.81	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	22.11	3.05	0.51	1.27	0.25	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	77.43	1.99	1.99	1.39	2.39	2.79
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	65.17	4.01	1.54	1.69	1.23	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	79.79	5.93	3.07	2.86	2.45	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	115.47	3.76	2.50	2.82	3.44	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	101.44	3.11	1.41	1.98	2.83	3.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	100.08	3.69	3.23	2.31	4.61	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	66.82	0.00	0.00	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	76.59	4.64	1.55	1.93	1.55	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	93.06	0.00	1.60	6.42	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	71.29	0.00	1.74	3.48	3.48	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	54.03	2.60	1.95	1.30	2.28	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	49.42	6.18	1.65	0.41	2.06	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	76.64	0.00	3.33	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	55.93	3.08	0.28	1.40	0.56	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	57.52	3.60	0.98	1.63	3.92	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	49.49	5.87	0.84	0.84	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	53.75	3.82	1.27	2.54	1.59	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	53.33	2.72	2.04	1.36	3.06	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	2.09	2.09	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	63.00	3.44	0.57	2.29	4.01	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	48.54	2.37	1.48	2.66	1.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	5.08	3.39	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	43.08	3.31	1.24	0.83	2.49	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	47.41	4.60	1.84	1.15	1.15	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	35.75	2.69	1.54	1.54	1.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	39.44	2.28	1.30	1.63	2.28	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	51.50	5.35	2.01	1.34	2.01	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	38.14	1.54	0.00	0.39	1.93	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	67.10	5.48	6.50	3.42	3.08	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	2.48	2.48	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	64.64	6.61	1.42	0.94	1.89	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	44.06	3.02	0.60	1.81	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	54.43	8.65	2.54	4.07	2.03	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	54.64	4.39	1.99	1.20	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	45.88	4.93	0.99	0.99	0.99	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	47.22	7.08	2.36	2.36	2.36	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	50.18	4.08	0.58	1.17	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	48.28	3.95	0.44	1.32	1.76	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	40.69	2.54	2.54	0.00	1.70	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	45.37	2.39	5.37	2.98	2.98	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	29.60	7.28	1.46	2.43	3.88	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	2.28	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.97	2.08	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	1.12	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	11.42	2.54	0.32	0.00	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.68	2.09	0.00	0.00	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.16	3.71	2.09	3.48	1.62	2.09
Hep-2 cells mock treated, biol_rep2	11899-125E9	38.32	3.71	2.70	2.70	2.03	2.03
Hep-2 cells mock treated, biol_rep3	11900-125F1	37.99	3.64	3.87	2.28	1.59	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	34.87	3.06	2.30	1.97	1.64	2.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	41.05	3.22	2.36	3.22	1.50	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	37.89	4.09	1.29	3.01	1.08	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	33.00	3.36	2.62	2.99	1.62	1.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	27.62	1.89	2.06	2.57	1.72	1.89
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	28.19	6.09	1.92	1.92	1.60	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	30.78	3.36	1.12	1.68	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.12	1.30	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	25.40	1.06	0.00	1.41	0.35	2.12
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	21.80	0.00	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.71	1.92	0.52	0.87	0.17	0.35
Hepatocyte, donor1	11523-119I2	52.06	4.84	3.63	1.21	1.21	1.21
Hepatocyte, donor2	11603-120I1	57.10	3.23	4.31	1.08	2.15	0.00
Hepatocyte, donor3	11684-122I1	49.70	4.91	3.68	3.07	0.61	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	66.57	3.92	1.96	1.96	0.00	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	52.26	11.19	2.97	4.02	2.27	1.92
Iris Pigment Epithelial Cells, donor1	11530-119I9	17.56	2.33	0.14	0.55	0.69	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	63.68	9.55	3.18	3.18	0.00	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	13.35	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	53.99	2.77	2.77	1.38	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	7.51	5.01	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	69.20	7.69	10.25	7.69	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	0.00	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	76.34	6.50	9.75	3.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	63.36	1.67	1.67	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	0.00	3.63	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	75.44	2.65	3.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	43.24	6.65	4.43	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	15.71	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	51.02	5.67	3.15	1.89	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	60.32	4.64	4.64	3.09	4.64	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	49.10	6.46	4.52	3.23	3.88	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	83.72	6.44	3.22	8.05	3.22	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	143.38	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	48.08	8.96	1.63	4.07	1.63	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	52.48	2.52	2.94	2.10	1.26	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	47.42	4.82	2.41	4.82	1.61	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	56.32	6.46	3.69	2.77	0.00	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	0.00	15.08	15.08	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	43.43	4.25	1.89	2.83	1.42	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	38.09	3.63	1.81	1.81	4.53	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	46.27	6.46	2.15	4.30	4.30	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	62.25	3.81	1.27	2.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	16.43	16.43	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	61.22	7.01	2.55	4.46	1.28	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	71.08	0.00	0.00	5.47	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	0.00	31.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	50.70	3.57	1.43	1.43	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	73.00	0.00	9.95	13.27	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	43.52	4.32	2.47	1.54	1.54	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	77.26	1.76	5.27	7.02	0.00	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	69.15	3.14	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	68.84	4.87	1.39	0.70	3.48	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	24.34	8.85	6.64	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	81.05	3.24	16.21	6.48	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	47.96	9.59	0.87	2.62	1.74	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	40.50	6.75	4.50	4.50	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	0.00	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	28.80	5.33	3.20	1.07	4.27	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	60.96	5.54	0.00	2.77	2.77	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	42.74	0.00	0.00	11.40	0.00	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	44.18	6.44	0.00	0.92	1.84	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	9.08	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	0.00	0.00	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	24.32	5.29	2.11	0.00	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	33.21	1.71	0.57	0.98	0.16	0.49
Keratinocyte - epidermal, donor2	11349-117G8	22.84	0.59	0.59	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	30.67	3.03	0.19	1.14	0.76	0.19
Keratinocyte - oral, donor1	11251-116E9	34.40	3.06	0.00	0.57	0.23	0.57
Keratocytes, donor1	11527-119I6	37.13	4.81	0.69	1.03	1.72	1.38
Keratocytes, donor2	11607-120I5	19.92	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	28.45	3.75	0.59	0.40	1.58	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	101.10	6.59	2.20	2.20	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	20.50	1.08	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	20.64	5.54	1.15	0.35	0.69	0.58
Lens Epithelial Cells, donor3	11690-122I7	30.98	0.81	0.20	0.71	0.40	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	24.78	3.56	0.59	0.47	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	14.79	2.51	0.56	0.28	0.28	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	19.52	3.46	0.63	0.79	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	17.21	2.15	1.61	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.70	2.52	0.00	0.95	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.23	1.51	0.86	0.22	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	19.29	0.82	0.00	0.00	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.88	1.52	0.51	0.25	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.08	2.67	0.42	0.84	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	16.61	1.19	0.40	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.99	1.55	0.97	0.58	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	12.03	1.30	0.00	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.59	2.09	1.39	0.70	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.55	2.62	0.24	1.19	0.72	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	16.62	1.92	0.14	0.27	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.94	0.31	0.62	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	14.03	1.87	0.00	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	17.57	2.20	0.18	0.18	0.91	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	15.47	1.97	0.33	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.64	2.64	0.29	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.69	1.49	0.75	0.25	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	16.49	3.88	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.43	3.23	0.27	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	17.71	2.27	0.15	0.15	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	14.52	2.07	0.52	0.52	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.75	2.30	0.21	0.00	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	18.35	2.56	0.90	0.30	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	14.30	1.13	0.56	0.38	0.19	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	14.63	3.07	0.42	0.74	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.41	2.42	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	17.53	2.65	1.32	0.33	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	15.61	2.35	0.37	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.62	4.44	0.00	0.37	0.00	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	18.28	1.48	0.49	0.25	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.71	1.51	0.14	0.27	0.82	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.80	0.96	0.32	0.32	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.69	1.83	0.61	0.00	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.20	2.24	0.98	0.56	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.07	1.42	0.00	0.71	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.12	0.48	0.97	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.89	2.02	0.00	0.62	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.10	0.72	0.00	0.00	0.36	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	20.25	2.29	0.65	0.33	0.00	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	11.77	1.41	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	22.40	3.22	0.37	0.74	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.83	1.54	0.51	0.51	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	15.22	1.79	0.00	0.00	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	2.27	2.27	2.27	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	29.92	3.07	0.00	1.53	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	26.72	1.48	0.74	0.00	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	25.81	2.54	2.54	2.54	0.42	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	17.58	0.70	0.00	0.00	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	18.68	1.87	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.46	0.52	2.58	0.52	0.00	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	20.22	1.19	1.19	1.19	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	23.30	2.49	0.90	0.68	0.23	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	29.66	2.62	0.87	0.29	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	24.76	0.90	0.45	1.35	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	31.16	3.39	0.41	0.95	0.00	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	37.49	3.59	1.03	1.03	1.54	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	25.41	2.82	0.00	2.47	0.71	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.99	0.67	0.67	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	34.64	2.55	3.57	1.53	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	29.35	2.67	1.07	0.53	0.53	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	27.02	4.91	0.94	1.13	0.57	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	30.06	1.84	0.61	0.61	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	26.09	1.63	0.82	2.45	1.63	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	25.41	5.00	1.67	1.46	0.42	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	23.82	3.64	0.84	1.12	0.28	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	25.76	4.12	0.00	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	28.45	4.64	0.58	1.74	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	28.10	3.89	1.49	0.90	0.30	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.22	1.66	0.55	1.11	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	24.39	2.83	1.06	1.06	0.00	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	26.18	3.32	1.48	1.84	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	23.03	3.45	1.15	2.30	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	27.25	1.54	0.77	2.30	0.00	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	23.21	4.53	0.57	1.13	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	17.23	4.92	1.64	0.82	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	26.66	0.90	0.90	0.90	0.00	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	22.98	1.44	0.00	1.44	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	21.66	5.98	0.00	0.00	2.99	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	25.64	1.86	1.86	0.74	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	20.68	1.29	1.72	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	30.83	2.57	2.57	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.66	1.67	0.67	2.00	0.33	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.27	1.81	0.60	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	11.38	2.13	0.71	0.71	1.42	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	24.75	0.69	1.37	1.37	0.34	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	19.86	2.15	0.00	0.00	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	2.69	0.00	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	26.30	2.22	0.00	0.37	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	18.61	3.49	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	25.39	1.06	1.06	2.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	21.21	2.40	0.80	0.80	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	38.52	2.91	0.00	1.45	2.18	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	31.43	1.53	1.53	1.53	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	32.56	3.45	0.00	0.99	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.05	0.00	0.00	1.88	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	31.68	4.02	1.01	0.50	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	30.19	1.80	0.45	1.35	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	29.26	1.72	0.00	3.44	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	25.83	3.56	0.45	1.34	0.45	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	33.24	3.52	1.17	1.56	0.00	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	25.73	2.64	0.66	2.64	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	37.36	1.56	0.52	0.52	0.52	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	29.32	4.81	0.88	0.00	1.75	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.87	2.24	2.80	1.68	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	33.56	4.42	0.88	1.77	0.44	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	28.54	3.09	1.16	1.93	1.16	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	23.80	2.53	1.52	1.52	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	34.60	3.84	0.96	1.92	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	27.83	2.78	0.40	1.19	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	35.24	1.82	0.00	3.04	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.91	1.38	1.38	0.69	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	24.70	3.42	0.00	0.38	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	28.92	2.07	0.52	0.52	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	21.77	1.81	0.00	1.21	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.52	1.27	0.63	1.90	0.95	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	44.78	2.13	0.00	1.60	0.00	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.26	2.30	0.57	0.57	0.00	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	24.17	2.06	1.54	0.51	1.03	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.17	2.83	0.71	1.41	1.41	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	19.29	1.13	0.57	0.57	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.46	1.66	1.25	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	1.57	3.13	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.23	2.92	0.00	1.67	0.84	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	37.17	2.32	0.00	0.00	0.46	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.06	0.67	1.34	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	28.87	1.60	1.07	1.07	1.07	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	22.63	0.40	0.81	1.21	0.40	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.94	2.75	0.92	0.00	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	23.12	1.78	1.78	0.00	1.78	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	32.48	1.14	0.57	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	25.31	3.07	0.77	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	15.87	1.09	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	26.28	2.67	0.45	1.34	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	27.04	1.56	0.26	0.52	0.78	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	21.22	1.99	1.33	1.99	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	31.91	5.24	1.14	0.23	0.23	0.91
Macrophage - monocyte derived, donor2	11313-117C8	42.39	4.40	1.47	0.92	0.18	0.73
Macrophage - monocyte derived, donor3	11389-118C3	30.67	4.72	1.31	0.66	0.39	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.12	2.12	0.53	0.53	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	15.21	2.69	0.63	0.32	0.00	0.79
Mallassez-derived cells, donor3	11930-125I4	24.32	2.64	1.11	0.97	0.00	0.56
Mammary Epithelial Cell, donor1	11273-116H4	58.89	3.49	1.10	1.40	1.20	1.30
Mammary Epithelial Cell, donor2	11350-117G9	44.01	2.32	1.16	1.16	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	22.70	2.49	1.25	1.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	18.30	1.36	0.00	0.68	0.68	0.00
Mast cell, donor1	11563-120D6	35.69	2.38	1.41	0.43	0.76	0.43
Mast cell, donor2	11565-120D8	65.68	4.16	0.59	0.30	0.30	0.59
Mast cell, donor3	11566-120D9	59.88	3.60	0.90	0.68	0.68	0.23
Mast cell, donor4	11567-120E1	70.21	3.55	0.89	1.06	0.35	1.60
Mast cell, expanded and stimulated, donor5	11940-126A5	41.92	3.22	0.78	0.44	0.11	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	51.95	2.33	1.17	0.00	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	33.04	2.75	0.34	0.69	0.34	0.23
Mast cell, expanded, donor8	11941-126A6	51.05	4.18	0.84	1.51	0.33	0.00
Melanocyte - dark, donor1	11502-119F8	22.98	2.59	0.50	0.99	0.80	0.20
Melanocyte - dark, donor2	11582-120F7	13.15	2.77	0.69	0.69	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	50.78	9.20	2.32	2.39	0.80	1.01
Melanocyte - light, donor1	11274-116H5	33.15	3.06	1.65	0.00	0.71	0.47
Melanocyte - light, donor2	11351-117H1	28.66	3.41	0.68	0.68	0.00	1.36
Melanocyte - light, donor3	11423-118G1	26.02	0.87	0.87	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	40.82	5.41	2.08	1.15	1.15	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	43.57	5.65	4.03	3.77	0.54	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	42.05	3.48	2.68	2.68	1.34	1.87
Meningeal Cells, donor1	11493-119E8	52.60	3.35	1.12	1.49	1.36	1.24
Meningeal Cells, donor2	11573-120E7	44.45	3.52	2.20	0.88	0.88	0.44
Meningeal Cells, donor3	11654-122E7	38.47	2.85	1.06	0.49	0.73	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	23.95	2.57	0.57	0.00	0.57	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.03	1.91	0.40	0.91	0.40	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	33.73	2.87	1.44	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	21.39	0.85	0.85	0.64	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.09	1.01	0.50	0.00	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	23.07	1.10	0.22	0.44	0.66	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	27.03	2.92	0.00	0.73	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	21.28	1.23	0.00	1.02	0.61	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	15.10	1.52	0.28	0.42	0.00	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	13.38	0.00	0.37	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	34.47	3.03	0.92	0.53	0.13	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.20	0.30	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	24.98	1.28	1.28	1.28	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	44.66	3.90	2.48	2.13	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	28.15	4.69	0.94	0.31	0.00	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	29.75	0.73	0.00	0.00	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	31.29	0.53	0.27	1.06	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	22.02	1.00	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	19.95	2.02	0.58	0.72	0.36	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	94.52	2.70	4.05	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	35.46	6.90	3.20	1.23	0.74	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	45.94	4.71	1.77	0.59	0.88	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	6.91	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	27.90	6.51	3.41	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	31.53	4.98	0.83	0.83	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	9.26	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	31.03	5.51	1.75	1.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	54.46	6.98	1.86	1.40	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	29.06	6.91	0.61	0.81	0.00	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	41.18	5.15	0.40	0.40	1.58	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	4.42	0.00	2.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	34.95	6.84	1.14	0.76	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	51.32	2.63	2.63	1.32	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	20.80	4.46	1.70	0.42	0.21	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	48.80	4.60	3.68	0.92	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	26.53	2.68	2.09	0.60	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	5.03	5.03	5.03	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	20.32	6.02	2.26	1.76	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	27.81	6.18	1.66	2.14	0.95	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	25.43	8.85	2.21	1.66	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	14.28	3.91	1.15	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	29.03	3.58	2.10	1.89	0.42	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	19.77	6.11	1.63	0.41	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.09	3.43	1.50	1.07	0.00	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	32.23	2.00	0.89	0.89	0.00	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	14.46	1.53	1.75	0.22	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	25.35	4.56	2.53	0.51	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	4.97	0.00	1.66	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	20.11	3.26	1.36	0.82	0.27	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	34.11	5.00	2.06	1.47	0.29	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	27.26	6.54	0.00	2.18	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	16.82	1.92	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	25.61	2.80	0.80	2.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	31.54	6.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	11.51	2.00	0.50	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	17.52	1.31	1.75	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	26.49	3.31	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.78	3.84	0.64	0.64	1.28	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	22.31	1.24	1.49	1.49	0.00	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	22.96	6.26	0.70	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	30.94	2.21	2.21	2.21	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.83	3.08	0.34	0.34	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	40.26	4.38	4.38	3.06	0.44	2.63
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	27.34	6.39	3.55	1.42	0.71	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	19.36	3.65	1.40	0.56	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	36.16	6.65	2.08	1.66	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	25.64	2.91	2.91	2.33	0.58	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	23.83	3.32	1.81	0.90	0.90	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	30.47	7.10	2.09	2.92	0.42	2.50
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	7.22	7.22	0.00	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	23.09	4.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	44.96	5.12	2.28	2.28	0.57	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	21.97	5.94	1.66	0.83	0.55	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	18.92	4.41	1.30	0.78	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	50.62	6.86	3.00	2.14	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	23.50	10.80	1.91	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	19.75	5.34	0.80	1.87	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	41.01	6.88	0.90	0.90	0.90	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	19.63	2.54	1.55	0.28	0.28	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	19.43	3.50	0.96	0.64	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	44.01	4.42	1.77	1.77	0.66	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	28.44	5.69	2.28	1.14	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.44	2.56	0.57	1.42	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	36.13	2.70	1.72	1.47	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	29.98	7.17	2.61	0.65	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	25.58	2.94	0.59	0.29	0.29	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	35.46	4.61	1.15	1.15	0.29	1.73
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	41.21	2.06	0.41	1.24	0.00	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.69	3.87	0.00	0.60	0.00	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	3.77	3.77	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	1.78	3.56	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	35.49	12.49	2.96	0.99	0.66	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	35.77	6.31	2.10	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	52.39	8.11	2.57	2.17	1.19	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	42.84	16.76	1.86	2.79	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	43.94	9.01	0.38	2.25	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	27.17	7.99	2.93	0.53	0.80	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	27.14	5.43	1.92	0.79	0.34	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	36.10	9.58	2.95	2.95	0.74	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	40.31	9.16	3.66	1.47	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	7.78	6.22	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	13.90	1.60	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	3.86	3.86	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	46.46	7.07	3.03	4.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.77	4.22	0.84	2.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	0.00	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	1.62	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	11.42	0.00	0.00	5.71	22.84
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	25.10	12.55	12.55	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	19.60	1.08	0.22	1.29	0.22	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	24.04	2.61	0.52	0.52	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	44.72	4.67	1.33	1.33	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	50.08	4.17	1.25	2.92	3.34	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	18.63	2.09	0.19	0.38	1.14	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	41.49	6.38	4.79	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	31.96	7.48	1.36	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	11.03	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	48.13	7.12	0.84	2.09	2.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	62.99	7.90	2.09	1.63	1.39	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	57.83	7.57	1.08	1.62	2.97	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	33.85	5.05	0.42	0.42	1.68	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	33.26	8.93	0.50	0.00	1.49	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.98	3.52	0.81	0.27	0.81	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	59.84	7.03	2.04	2.72	1.81	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	53.56	7.68	1.63	0.98	1.14	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	29.89	5.10	1.82	0.91	1.82	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	42.97	11.14	1.59	0.53	2.65	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	34.82	4.80	4.80	0.60	4.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.88	0.66	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	52.53	6.50	1.63	2.28	2.60	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	40.57	4.76	1.23	1.59	1.76	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	48.52	8.44	1.41	2.81	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	52.87	5.06	1.84	0.92	3.22	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	65.88	8.68	2.57	1.29	2.89	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	12.07	0.00	0.69	0.00	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	7.59	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	45.00	4.23	2.45	2.01	0.67	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	55.04	5.50	2.12	2.12	2.12	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.01	2.14	0.47	0.71	1.90	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	72.54	13.31	4.29	3.86	2.58	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	60.98	4.33	2.67	2.67	2.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	47.34	4.06	2.25	2.71	2.71	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	51.58	4.36	0.79	1.59	1.19	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	59.43	13.00	5.57	0.93	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	33.68	4.54	1.89	0.38	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	49.86	4.56	1.63	3.58	1.96	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	33.56	6.97	0.44	0.00	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	46.59	4.52	2.71	0.45	1.36	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	53.80	0.88	2.65	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	49.20	6.65	0.66	1.33	2.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	40.68	9.92	1.49	1.98	1.49	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	53.60	1.91	1.15	1.53	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	34.18	4.23	0.60	0.00	0.30	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	33.82	1.77	0.44	1.11	0.44	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	51.50	7.45	2.03	4.07	1.36	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	53.04	10.36	2.44	1.22	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	58.54	3.46	0.31	0.63	0.63	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	39.04	7.57	0.30	0.91	1.82	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.14	8.70	3.96	2.37	3.16	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	1.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	16.90	1.99	0.62	0.25	0.50	0.62
Myoblast, donor2	11322-117D8	23.78	3.45	0.19	0.96	0.58	0.38
Myoblast, donor3	11398-118D3	28.92	1.35	0.50	1.18	1.01	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	71.65	16.20	4.52	2.77	4.52	1.02
Natural Killer Cells, donor1	11230-116C6	49.82	3.69	1.54	2.15	0.62	0.62
Natural Killer Cells, donor2	11311-117C6	51.26	4.52	3.02	1.21	0.90	0.30
Natural Killer Cells, donor3	11387-118C1	46.01	6.07	2.21	2.02	0.92	0.37
Neural stem cells, donor1	11275-116H6	49.00	2.90	1.81	0.36	1.09	0.36
Neural stem cells, donor2	11352-117H2	36.59	1.93	5.78	0.00	0.00	0.00
Neurons, donor1	11494-119E9	37.55	2.28	1.14	2.28	0.00	3.41
Neurons, donor2	11574-120E8	28.18	2.20	0.44	0.66	0.66	0.00
Neurons, donor3	11655-122E8	55.09	10.69	1.64	1.64	0.00	2.47
Neutrophils, donor1	11233-116C9	12.99	0.93	0.00	0.93	0.00	1.86
Neutrophils, donor2	11314-117C9	14.49	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	26.27	1.22	0.61	1.22	0.61	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	21.85	2.37	0.59	0.83	0.59	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	20.19	1.95	0.33	0.65	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	21.26	1.80	0.60	0.00	0.60	0.00
Olfactory epithelial cells, donor1	11933-125I7	42.67	8.40	1.65	1.10	1.10	0.55
Olfactory epithelial cells, donor2	11934-125I8	41.40	5.93	1.01	1.30	1.45	0.87
Olfactory epithelial cells, donor3	11935-125I9	32.80	4.99	1.14	0.79	0.45	0.45
Olfactory epithelial cells, donor4	11936-126A1	37.89	3.70	0.68	0.88	0.58	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	19.26	3.01	0.00	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	21.48	0.64	0.21	0.21	0.85	0.21
Osteoblast - differentiated, donor2	11353-117H3	13.72	2.29	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.86	4.97	0.62	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	20.52	2.54	0.39	0.20	0.20	0.78
Osteoblast, donor2	11354-117H4	25.99	1.40	0.00	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	31.81	2.49	0.71	1.96	0.89	0.00
Pancreatic stromal cells, donor1	11249-116E7	18.87	1.68	0.25	0.34	0.34	0.51
Pericytes, donor1	11491-119E6	14.13	0.89	0.22	0.45	0.11	0.22
Pericytes, donor2	11571-120E5	17.88	0.68	0.00	0.68	0.68	0.91
Pericytes, donor3	11652-122E5	19.12	1.63	0.61	0.81	0.41	0.61
Perineurial Cells, donor1	11499-119F5	24.53	2.83	0.68	0.34	0.23	0.34
Perineurial Cells, donor2	11579-120F4	21.25	3.31	0.37	0.46	0.64	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	49.72	5.42	0.96	0.64	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	38.69	7.84	2.20	2.94	0.98	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	37.79	5.56	2.07	1.42	1.04	0.52
Placental Epithelial Cells, donor1	11278-116H9	41.61	0.96	0.48	2.87	0.96	1.67
Placental Epithelial Cells, donor2	11355-117H5	17.74	3.33	1.11	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	19.24	5.30	0.20	0.20	0.79	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	15.82	1.27	0.00	0.00	0.63	0.63
Preadipocyte - breast, donor1	11467-119B9	25.70	1.88	0.38	0.19	0.38	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	24.15	1.31	0.13	0.65	0.39	0.13
Preadipocyte - breast, donor2	11328-117E5	27.02	2.25	0.23	0.45	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	28.02	1.70	0.32	0.43	0.21	0.43
Preadipocyte - omental, donor2	11329-117E6	21.82	1.75	0.44	1.31	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	21.77	2.15	0.57	0.29	0.72	0.72
Preadipocyte - perirenal, donor1	11469-119C2	21.65	3.94	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	25.80	1.84	0.31	0.31	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	43.56	1.42	0.71	0.89	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	25.71	3.92	0.68	0.68	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	38.38	2.33	0.93	0.75	0.84	0.56
Preadipocyte - visceral, donor2	11357-117H7	22.55	2.30	0.46	0.92	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	31.66	2.51	0.84	0.73	0.73	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	38.47	4.37	2.87	3.17	0.91	2.11
Prostate Epithelial Cells, donor2	11331-117E8	12.19	1.76	0.27	0.81	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	21.37	1.78	0.31	0.61	0.31	0.86
Prostate Stromal Cells, donor1	11254-116F3	20.96	2.16	0.34	0.46	1.03	0.80
Prostate Stromal Cells, donor2	11332-117E9	28.51	1.61	0.54	1.08	0.90	0.36
Prostate Stromal Cells, donor3	11405-118E1	17.62	1.67	0.00	0.42	0.42	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	24.82	0.73	0.73	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.21	2.63	0.49	0.55	0.21	0.28
Renal Epithelial Cells, donor1	11517-119H5	17.75	0.00	0.00	0.51	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	19.92	2.85	0.71	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	24.67	3.28	0.42	0.21	0.85	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	20.43	0.68	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	35.17	3.23	0.67	0.67	0.94	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	32.64	3.11	1.55	0.22	1.55	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.31	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	17.17	0.66	0.66	0.44	0.00	0.66
Renal Mesangial Cells, donor2	11598-120H5	20.06	0.00	1.25	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	9.71	0.55	0.00	0.55	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	42.41	5.10	2.68	3.22	1.88	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	22.35	0.42	1.69	1.27	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	32.21	2.89	0.58	0.77	0.58	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	36.56	4.93	2.59	1.56	0.52	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	36.67	2.84	0.57	1.42	1.14	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	16.47	0.00	0.00	1.03	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	27.35	3.51	0.75	1.00	1.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	35.68	2.94	0.80	1.20	0.40	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	36.63	5.36	3.57	0.89	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.31	1.65	2.20	0.55	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	29.00	2.32	2.32	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	39.40	2.47	1.95	2.08	1.17	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	41.71	7.05	2.98	2.98	1.29	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	47.07	4.68	2.34	1.67	1.34	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	31.26	4.34	2.11	1.86	1.24	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	39.04	5.13	1.98	1.98	1.05	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	43.22	5.78	1.62	3.47	1.39	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	36.28	3.83	1.78	2.60	2.19	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	32.22	5.14	2.12	2.12	1.82	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	53.94	5.55	4.12	2.33	1.43	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	33.28	3.87	2.87	1.43	2.01	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	33.48	4.08	1.82	1.72	1.18	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	43.15	3.98	5.31	4.43	1.33	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	31.35	2.87	2.87	1.72	1.91	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	40.62	5.50	2.52	2.42	1.21	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	54.68	4.70	2.25	3.01	0.94	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	42.73	5.31	3.98	3.58	1.73	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	38.74	5.26	3.89	2.04	1.56	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	44.88	8.98	3.63	2.10	1.72	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	34.17	4.06	2.46	2.24	1.92	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	36.72	3.64	1.96	2.24	1.40	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	47.34	6.32	3.59	3.76	1.71	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	43.03	6.56	3.10	2.92	1.09	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	40.96	6.38	2.21	2.58	1.47	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	42.45	6.98	2.82	1.75	2.28	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	28.30	4.01	1.65	3.07	2.12	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	44.25	6.94	3.57	2.98	1.39	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	50.04	5.14	2.10	5.38	1.40	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	33.59	7.26	3.94	3.11	1.24	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	34.95	7.30	3.32	2.43	0.88	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	54.52	7.31	3.97	5.01	1.67	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	36.20	4.04	3.50	1.75	1.35	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	49.04	8.86	5.28	3.58	0.85	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	55.72	7.33	4.43	2.89	1.54	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	30.60	2.41	2.24	0.86	1.38	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	48.56	10.01	3.57	2.74	1.10	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	43.83	7.72	4.60	3.78	1.64	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	24.88	4.77	1.70	1.70	1.87	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	36.10	5.92	2.81	2.22	1.18	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	38.65	4.00	4.00	0.53	1.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	30.00	3.73	3.18	1.66	2.35	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	35.95	7.38	1.19	2.86	1.43	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	44.54	7.86	4.03	1.41	1.01	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	22.04	4.43	2.64	1.60	1.13	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	29.35	4.19	2.10	2.10	1.05	3.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.31	9.07	3.93	1.51	1.21	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	22.64	3.43	2.33	1.22	1.47	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	54.00	6.11	2.77	2.77	2.47	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	31.64	5.48	3.65	1.22	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	24.41	3.92	4.52	0.90	2.11	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	30.99	6.11	2.94	1.58	1.81	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	42.83	3.59	4.19	1.20	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	28.69	3.31	2.01	2.48	1.42	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	28.39	6.62	2.56	2.77	1.49	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	30.05	9.62	1.20	1.20	0.60	1.80
Schwann Cells, donor1	11498-119F4	18.81	1.50	0.00	0.38	0.00	0.38
Schwann Cells, donor2	11578-120F3	13.61	0.00	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	21.47	1.31	0.22	0.44	0.22	0.00
Sebocyte, donor1	11220-116B5	33.41	1.64	1.10	0.55	0.55	1.10
Sebocyte, donor2	11301-117B5	32.63	2.76	0.00	0.46	0.46	0.46
Sebocyte, donor3	11378-118B1	17.52	2.89	0.41	0.00	0.62	0.21
Sertoli Cells, donor1	11255-116F4	28.16	3.31	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	16.95	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	29.30	3.78	0.26	0.70	0.70	0.53
Skeletal Muscle Cells, donor2	11358-117H8	15.90	0.00	0.00	0.72	1.45	1.45
Skeletal Muscle Cells, donor3	11430-118G8	23.41	5.85	0.84	0.00	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	42.57	4.71	1.73	0.94	1.26	0.94
Skeletal Muscle Cells, donor5	11455-119A6	52.77	5.20	1.04	0.89	2.23	0.59
Skeletal Muscle Cells, donor6	11459-119B1	61.71	4.62	1.69	2.15	0.46	1.69
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.21	4.66	0.88	0.38	0.63	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	30.96	4.42	0.29	0.86	0.43	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	45.93	3.27	1.29	1.29	0.89	0.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	35.39	3.03	0.93	0.51	0.67	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	30.40	2.17	0.00	2.17	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.41	2.89	0.69	0.83	0.41	0.28
Skin - palm, donor1	10286-104F7	61.78	21.49	5.37	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	28.40	2.16	0.58	1.15	0.29	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	41.71	0.00	0.82	0.00	3.27	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	30.90	2.73	0.91	1.30	0.52	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	24.05	2.22	0.56	1.11	0.28	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	27.99	4.08	1.83	1.69	0.56	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	61.53	4.02	1.06	1.90	0.21	3.38
Small Airway Epithelial Cells, donor3	11406-118E2	28.33	3.67	0.60	0.75	0.60	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.65	0.93	0.62	0.00	0.31	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.79	0.22	0.22	0.89	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	18.22	1.76	0.59	0.59	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.90	1.33	0.44	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	22.84	0.79	0.79	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	38.63	0.77	0.77	2.32	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	28.02	6.00	1.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	18.36	1.20	0.13	0.40	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	18.18	3.10	0.44	0.66	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	34.31	3.33	1.15	1.15	0.51	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	25.07	2.28	0.00	0.00	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	27.17	0.59	0.59	0.89	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.93	1.85	0.43	0.43	0.28	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	13.83	0.65	0.00	0.33	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.92	3.35	0.91	0.00	0.30	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	22.23	1.01	0.25	0.25	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.87	1.91	1.43	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	18.29	0.88	0.74	0.59	0.00	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	22.17	3.66	0.43	0.43	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	26.03	2.41	0.84	0.21	0.00	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.26	1.55	0.00	0.31	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	20.48	4.31	0.00	0.00	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.63	2.69	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	13.31	1.37	0.00	0.34	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	22.69	2.51	0.55	0.16	0.79	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	24.86	2.31	0.50	0.50	0.20	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.71	1.82	0.23	0.91	0.68	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	18.11	1.81	0.60	0.60	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	58.55	2.65	0.53	1.32	0.26	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	24.23	2.40	0.27	0.27	1.07	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	21.04	3.01	0.75	0.50	0.50	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.37	2.03	0.76	0.00	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	23.07	2.11	0.30	0.45	0.30	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	23.26	3.00	0.75	0.75	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	25.84	2.58	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	32.55	0.00	0.00	0.47	0.00	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	13.63	2.52	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	20.68	1.57	0.31	0.31	0.31	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	11.50	0.59	0.00	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	39.24	3.67	1.25	0.33	0.67	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	16.35	3.74	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.41	1.44	0.58	0.00	0.00	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	19.63	3.57	1.27	0.51	0.76	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	20.12	5.45	0.94	1.13	0.75	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	21.24	2.38	0.28	0.00	0.28	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	20.53	1.68	0.42	0.34	0.25	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.05	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.95	0.73	0.00	0.00	0.24	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	36.24	1.77	0.66	0.44	0.44	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	17.55	1.46	0.00	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.35	2.92	0.58	0.39	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.49	0.79	0.79	0.53	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	5.95	0.00	0.00	0.00	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	13.65	0.72	0.00	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	16.18	0.85	0.28	0.28	0.00	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	22.84	1.58	0.39	1.18	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	13.71	1.52	0.25	0.00	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	13.58	1.20	0.00	0.40	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	17.56	3.76	0.84	0.00	0.42	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	15.13	2.29	1.38	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	25.92	2.36	0.84	0.34	0.67	0.00
Synoviocyte, donor2	11368-117I9	14.25	3.35	0.34	0.84	0.00	0.00
Synoviocyte, donor3	11440-118H9	17.87	3.57	0.45	0.45	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	32.52	1.43	0.71	2.14	0.36	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	19.22	1.39	0.23	0.23	1.16	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	30.54	1.51	0.57	0.65	0.14	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	18.94	3.09	0.39	0.77	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	20.04	2.29	2.86	1.72	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	37.40	4.31	0.62	1.35	0.74	1.23
Urethra, donor2	10319-105A4	68.34	10.79	7.19	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	15.94	1.06	0.27	0.53	0.00	0.53
Urothelial Cells, donor2	11600-120H7	16.42	2.00	0.40	0.80	0.00	0.80
Urothelial Cells, donor3	11681-122H7	15.13	0.69	0.23	0.00	0.23	0.46
Urothelial cells, donor0	11216-116B1	27.64	2.90	0.67	0.22	0.45	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	14.24	0.89	0.89	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	21.44	2.86	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	14.37	0.00	1.37	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	27.55	3.10	1.72	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	29.63	3.49	0.58	0.00	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	20.82	2.08	0.00	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	16.52	1.84	0.00	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	17.35	0.91	0.91	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	88.82	15.30	2.10	4.44	2.47	2.84
Wilms' tumor cell line:HFWT	10597-108E3	113.53	7.92	6.16	3.52	6.16	7.92
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	57.26	6.70	3.91	1.96	3.35	0.84
achilles tendon, donor2	10292-104G4	16.53	6.20	6.20	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	77.51	6.37	2.80	4.84	3.57	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	66.40	7.20	5.11	2.32	1.39	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	53.42	4.75	2.61	3.09	3.44	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	82.99	4.08	2.45	3.81	2.45	2.45
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	71.68	7.59	4.22	4.22	2.53	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	46.53	3.81	1.90	0.85	1.69	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	11.71	1.36	0.00	0.27	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	69.62	14.98	5.73	2.20	1.76	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	49.41	11.43	2.86	0.82	2.04	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	120.76	14.37	9.71	5.05	3.49	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	63.85	7.36	2.02	2.39	2.02	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	7.80	3.90	11.70	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	56.00	10.22	3.49	2.09	2.09	2.09
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	51.00	6.47	2.33	1.04	0.78	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	54.36	3.21	2.05	1.75	0.58	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	54.84	3.72	5.58	1.39	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	36.19	8.64	3.29	1.23	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	155.62	24.25	16.88	7.37	6.45	2.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	62.30	6.40	5.55	2.99	4.27	3.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	47.62	9.40	3.94	1.21	1.21	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	54.64	9.15	2.89	1.20	2.17	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	51.45	6.24	1.78	2.23	1.11	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	78.05	3.00	4.67	2.67	2.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	63.18	5.57	1.86	3.72	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	49.34	1.13	1.13	0.38	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	48.85	9.16	1.74	1.31	0.87	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	37.49	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	119.87	38.15	9.89	10.13	5.18	1.88
adipose tissue, adult, pool1	10010-101C1	23.58	3.57	1.40	0.62	0.31	0.31
adipose, donor1	10184-103D4	24.63	0.00	0.00	0.00	0.00	0.59
adipose, donor2	10185-103D5	38.93	2.84	0.41	0.00	1.62	0.81
adipose, donor3	10186-103D6	46.83	5.45	0.54	0.54	0.82	1.09
adipose, donor4	10187-103D7	55.47	0.87	0.87	0.87	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	62.18	10.26	0.79	0.79	1.42	2.84
adrenal gland, adult, pool1	10081-102A9	65.48	10.91	3.64	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	42.69	4.40	1.60	0.93	0.93	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	48.95	4.64	1.43	1.79	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	32.92	3.48	1.16	1.16	0.70	2.09
amniotic membrane cells, donor2	12236-129G4	37.53	2.70	0.00	0.68	1.35	1.35
amniotic membrane cells, donor3	12237-129G5	25.04	2.06	0.29	0.88	0.59	1.77
amygdala - adult, donor10196	10167-103B5	52.18	0.00	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	36.90	9.12	0.81	1.22	0.20	1.42
amygdala, newborn, donor10223	10360-105E9	27.11	1.61	1.29	1.29	0.32	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	34.12	5.73	2.16	0.76	2.29	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	65.08	2.87	0.22	3.09	1.54	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	111.90	14.70	6.01	5.34	4.34	2.67
aorta, adult, pool1	10052-101G7	33.54	4.31	0.20	0.98	0.59	0.59
appendix, adult	10189-103D9	52.78	10.48	3.49	0.39	2.33	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	63.28	12.38	4.47	1.72	5.50	1.38
artery, adult	10190-103E1	51.63	42.12	8.15	8.15	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	48.39	8.11	3.04	1.59	1.74	1.01
b cell line:RPMI1788	10427-106D4	57.55	5.95	4.01	3.12	2.23	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	19.98	1.66	0.28	0.55	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	26.89	1.89	0.99	2.08	1.09	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	62.43	3.51	3.01	3.35	2.01	1.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	63.19	10.07	2.24	2.80	1.68	0.00
bladder, adult, pool1	10011-101C2	30.53	2.17	0.33	0.76	0.22	0.65
blood, adult, pool1	10053-101G8	37.65	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	35.11	7.71	1.71	0.00	0.86	0.00
bone marrow, adult	10192-103E3	28.34	5.40	1.35	0.67	3.37	0.67
brain, adult, donor1	10084-102B3	80.98	6.15	1.03	0.00	2.05	0.00
brain, adult, pool1	10012-101C3	38.42	6.12	0.56	1.45	0.00	0.89
brain, fetal, pool1	10085-102B4	117.54	13.36	0.00	5.34	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	99.77	6.28	2.31	4.63	3.63	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	79.01	7.36	3.74	2.12	1.37	0.75
breast, adult, donor1	10080-102A8	44.19	6.31	2.53	2.53	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	56.66	9.91	1.65	2.92	0.76	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	71.43	24.43	5.26	3.09	2.16	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	17.96	2.30	0.00	0.23	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	77.71	10.17	4.60	2.91	1.21	1.45
carcinoid cell line:NCI-H1770	10703-109H1	85.10	19.75	1.88	3.29	0.47	2.35
carcinoid cell line:NCI-H727	10735-110B6	65.96	5.80	3.72	4.05	2.63	2.52
carcinoid cell line:SK-PN-DW	10719-109I8	26.62	2.22	0.32	0.95	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	78.79	13.04	4.79	2.40	4.53	2.93
caudate nucleus - adult, donor10196	10177-103C6	52.96	10.36	2.30	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	41.50	9.04	0.84	2.84	0.17	1.67
caudate nucleus, adult, donor10258	10379-105H1	47.38	9.17	0.00	3.06	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	29.66	1.10	2.20	0.73	0.37	1.46
cerebellum - adult, donor10196	10173-103C2	67.01	8.74	0.00	0.00	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	45.90	6.19	1.92	1.28	0.64	0.64
cerebellum, adult, pool1	10083-102B2	74.16	18.97	2.41	2.07	0.69	0.69
cerebellum, newborn, donor10223	10357-105E6	29.06	1.66	1.66	0.83	1.66	3.32
cerebral meninges, adult	10188-103D8	41.10	7.82	0.50	1.26	0.50	1.01
cerebrospinal fluid, donor2	10294-104G6	40.93	21.93	5.12	2.19	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	80.66	9.49	2.59	3.59	3.59	1.29
cervical cancer cell line:ME-180	10553-107I4	51.87	3.48	1.82	3.48	0.83	1.66
cervix, adult, pool1	10013-101C4	34.12	2.62	0.73	0.63	0.31	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	79.28	5.02	1.53	1.53	0.84	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	10.45	1.31	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	33.31	4.47	1.24	1.12	0.75	0.50
choriocarcinoma cell line:SCH	10785-110H2	39.30	2.34	0.49	1.23	1.97	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	49.10	8.78	4.98	1.66	3.08	2.61
chorionic membrane cells, donor1	12238-129G6	22.79	2.28	1.14	0.57	1.14	1.14
chorionic membrane cells, donor2	12239-129G7	24.26	3.08	0.60	0.50	0.50	0.50
chorionic membrane cells, donor3	12240-129G8	15.39	4.40	1.10	2.20	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	33.32	8.08	4.04	2.02	3.03	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	63.01	11.91	2.69	1.54	2.31	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	66.52	6.55	2.11	1.27	1.48	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	73.70	6.93	1.28	2.57	1.28	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	82.24	10.88	2.42	2.66	1.21	2.18
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	65.56	7.53	2.85	1.43	2.04	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	214.66	10.31	5.89	6.18	3.24	3.24
chronic myelogenous leukemia cell line:KU812	10409-106B4	51.60	1.04	1.56	0.78	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	30.86	2.97	0.91	0.46	0.91	0.23
clear cell carcinoma cell line:TEN	10636-108I6	87.10	10.93	10.58	3.12	4.86	3.30
colon carcinoma cell line:CACO-2	10513-107D9	64.06	11.17	6.04	2.56	3.84	1.83
colon carcinoma cell line:COLO-320	10420-106C6	80.58	6.08	1.52	1.52	0.76	0.76
colon, adult, donor1	10082-102B1	160.65	20.23	9.52	7.14	9.52	1.19
colon, adult, pool1	10014-101C5	84.25	6.93	4.11	6.23	4.00	3.06
colon, fetal, donor1	10070-101I7	118.65	19.78	4.94	5.56	2.47	4.33
common myeloid progenitor CMP, donor1	12130-128D6	288.76	4.58	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	68.84	9.35	5.10	2.97	2.97	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	54.18	9.06	2.11	2.72	4.23	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	58.80	7.33	3.81	2.82	4.65	2.12
corpus callosum, adult, pool1	10042-101F6	45.88	1.88	0.22	1.55	0.11	1.22
cruciate ligament, donor2	10295-104G7	34.04	8.10	0.81	1.62	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	101.93	24.88	10.43	10.43	2.41	0.80
diencephalon, adult	10193-103E4	31.68	5.28	0.96	1.68	0.24	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	66.36	11.02	5.51	3.21	2.98	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	118.73	15.13	6.41	6.41	2.56	2.56
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	63.07	1.69	2.41	1.20	0.72	2.65
ductus deferens, adult	10196-103E7	37.38	7.97	3.49	1.50	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	123.86	14.40	8.64	5.76	8.64	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	47.82	8.83	0.74	2.94	1.47	2.94
dura mater, adult, donor1	10041-101F5	37.99	5.62	0.83	0.33	0.41	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	72.62	6.00	7.33	6.22	4.66	12.88
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	64.91	1.58	1.72	1.58	2.29	3.30
embryonic pancreas cell line:1B2C6	10604-108F1	73.38	8.02	7.40	1.23	3.70	3.08
embryonic pancreas cell line:1C3D3	10605-108F2	48.13	9.08	1.51	0.30	0.61	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	92.62	15.13	6.79	3.09	4.63	3.09
embryonic pancreas cell line:2C6	10603-108E9	60.42	17.08	2.63	2.63	3.94	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	77.77	12.07	2.68	2.68	3.02	4.02
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	39.33	3.62	0.54	0.72	1.45	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	46.80	2.57	2.41	3.06	0.80	0.64
epidermoid carcinoma cell line:A431	10426-106D3	62.92	3.11	2.11	3.11	1.78	1.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	42.01	6.16	2.86	2.42	2.09	1.43
epididymis, adult	10197-103E8	27.21	10.47	0.84	1.05	0.63	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	55.71	0.53	0.00	1.06	0.35	2.48
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	38.93	3.93	0.00	0.79	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	56.88	11.27	5.37	4.46	3.54	3.80
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	52.95	10.24	4.72	4.13	2.85	2.17
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	57.47	11.99	3.58	5.38	2.58	2.24
esophagus, adult, pool1	10015-101C6	31.75	4.14	0.64	0.74	0.64	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	91.05	1.25	0.63	3.01	0.63	1.50
eye - muscle inferior rectus, donor1	10272-104E2	77.27	16.90	4.83	12.07	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	92.58	37.88	12.63	8.42	4.21	2.10
eye - muscle medial, donor2	10299-104H2	110.13	31.25	7.44	5.95	0.00	1.49
eye - muscle superior, donor2	10297-104G9	50.45	16.05	3.44	3.44	3.44	2.29
eye - vitreous humor, donor1	10268-104D7	20.40	2.91	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	40.68	5.34	2.54	1.02	0.25	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	52.06	6.92	1.67	1.67	0.77	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	42.74	1.66	2.85	2.85	1.19	3.32
frontal lobe, adult, pool1	10040-101F4	54.79	6.00	0.84	1.22	0.38	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	175.05	12.91	4.80	9.61	5.40	4.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	46.36	5.12	0.91	0.37	0.55	0.73
gall bladder, adult	10198-103E9	29.70	7.48	2.66	1.45	0.48	0.72
gamma delta positive T cells, donor1	11937-126A2	62.28	4.83	0.54	0.54	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	58.26	1.49	1.87	1.49	1.12	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	37.81	7.18	2.32	2.11	1.69	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	58.41	8.90	1.93	2.90	1.74	0.97
gastric cancer cell line:AZ521	10549-107H9	70.17	7.05	3.28	1.64	2.30	2.62
gastric cancer cell line:GSS	10560-108A2	61.32	0.92	0.00	0.00	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	47.98	9.60	7.08	1.37	4.11	2.51
giant cell carcinoma cell line:LU65	10487-107B1	44.63	3.79	1.84	1.26	1.26	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	35.69	0.42	0.42	0.14	0.56	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	57.86	15.46	3.24	3.24	1.50	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	42.43	2.53	0.74	0.95	0.63	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	66.15	2.53	0.98	3.09	0.42	1.40
glioblastoma cell line:T98G	10485-107A8	36.09	2.21	1.10	1.43	1.21	0.77
glioma cell line:GI-1	10413-106B8	36.90	8.49	2.93	0.59	2.05	0.59
globus pallidus - adult, donor10196	10175-103C4	75.08	7.29	0.00	1.46	0.73	2.19
globus pallidus, adult, donor10252	10161-103A8	37.35	3.17	0.73	0.73	0.00	3.42
globus pallidus, adult, donor10258	10367-105F7	27.38	8.22	0.00	1.37	1.37	4.11
globus pallidus, newborn, donor10223	10364-105F4	36.77	3.20	1.60	2.13	0.00	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	332.81	24.47	14.68	7.34	12.24	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	21.86	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	32.00	4.16	0.00	0.00	0.64	0.64
hIPS +CCl2, biol_rep1	14383-156B9	72.08	4.59	1.84	1.84	2.30	3.21
hIPS +CCl2, biol_rep2	14384-156C1	60.36	1.83	0.91	2.29	1.37	4.57
hIPS +CCl2, biol_rep3	14385-156C2	90.82	2.58	3.22	1.93	2.58	3.86
hIPS, biol_rep1	14380-156B6	70.43	1.44	2.87	8.62	2.87	4.31
hIPS, biol_rep2	14381-156B7	88.48	1.37	2.06	4.12	2.06	6.17
hIPS, biol_rep3	14382-156B8	43.04	2.21	1.10	1.10	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	54.88	4.31	4.02	2.30	2.30	1.44
heart - mitral valve, adult	10205-103F7	48.73	10.46	2.39	2.39	1.20	2.99
heart - pulmonic valve, adult	10206-103F8	90.99	12.03	2.88	9.15	2.61	2.61
heart - tricuspid valve, adult	10207-103F9	49.96	5.83	1.67	3.33	1.67	5.00
heart, adult, diseased post-infarction, donor1	10050-101G5	109.37	15.92	3.67	7.35	2.65	3.67
heart, adult, diseased, donor1	10051-101G6	155.43	14.48	12.35	8.52	3.41	2.55
heart, adult, pool1	10016-101C7	164.20	9.20	5.52	10.35	5.75	5.06
heart, fetal, pool1	10046-101G1	159.15	13.55	9.04	11.81	4.72	8.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	34.55	4.63	0.62	0.00	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	41.62	5.95	3.57	1.19	4.76	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	57.46	13.37	2.21	3.31	3.76	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	62.02	10.68	2.18	3.88	2.91	2.18
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	58.81	9.20	2.53	2.73	2.73	2.02
hepatoma cell line:Li-7	10484-107A7	87.53	3.56	2.34	2.89	4.23	2.34
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	65.12	15.58	5.93	4.52	3.52	2.11
hippocampus - adult, donor10196	10169-103B7	66.24	4.73	0.95	2.84	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	42.45	6.33	0.61	1.43	1.22	0.82
hippocampus, adult, donor10258	10374-105G5	36.35	0.50	0.50	1.49	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	43.00	3.17	1.41	1.06	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	109.25	0.61	0.61	1.83	1.83	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	97.20	2.16	2.36	2.55	2.16	2.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	79.22	0.76	2.29	1.52	2.54	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	36.09	1.69	1.13	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	28.66	3.10	0.26	0.52	0.00	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	23.54	1.52	0.00	0.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	29.78	2.92	1.75	0.58	0.58	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	39.21	3.88	0.65	1.08	0.65	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	47.55	2.50	0.83	2.92	1.67	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	45.94	3.79	1.42	2.13	1.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	49.66	4.98	0.80	1.77	1.93	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	50.50	6.73	2.02	3.37	3.37	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	76.99	2.66	2.97	1.56	2.50	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	72.22	2.46	4.91	0.49	2.95	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	60.22	0.87	3.49	0.00	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	33.22	2.67	0.19	0.57	0.76	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	37.50	2.62	1.31	0.00	3.05	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	30.49	3.00	0.00	0.50	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	26.19	4.33	0.38	0.57	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	24.55	4.09	0.00	1.82	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	27.56	2.19	0.94	0.31	1.57	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	34.13	2.94	0.82	1.31	0.82	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	35.13	5.52	1.45	1.16	0.29	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	29.00	4.48	1.79	0.30	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	87.01	2.40	2.03	2.40	3.69	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	105.27	3.42	1.43	3.42	3.71	3.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	75.54	3.67	4.49	1.63	1.63	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	29.57	0.35	1.06	1.06	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	37.69	1.90	0.95	1.27	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	32.68	2.72	0.61	0.61	0.30	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	34.13	3.10	1.55	0.52	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	40.51	1.99	0.00	1.99	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	26.94	2.82	0.26	1.54	0.77	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	33.75	2.81	1.02	1.28	1.53	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	48.46	4.54	0.00	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	36.97	2.02	0.67	1.01	1.01	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	90.81	2.17	2.42	2.42	4.11	4.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	66.40	1.34	2.67	1.34	2.67	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	82.93	1.95	3.41	2.93	3.41	3.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	25.06	2.75	0.31	0.61	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	29.28	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	22.84	1.32	0.00	0.66	0.99	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	35.57	2.74	1.09	0.55	1.09	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	30.04	1.45	0.72	0.72	0.36	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	28.11	2.85	0.36	1.42	0.36	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	40.58	1.19	0.00	1.19	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	40.63	2.03	0.81	0.68	0.68	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	32.33	2.69	0.54	1.08	0.81	0.81
immature langerhans cells, donor1	11904-125F5	33.42	3.87	2.18	0.97	0.00	0.97
immature langerhans cells, donor2	11905-125F6	53.86	7.13	3.17	2.38	0.00	4.75
insula, adult, pool1	10039-101F3	59.52	5.02	1.14	0.95	0.38	1.23
keratoacanthoma cell line:HKA-1	10791-110H8	68.93	21.13	3.58	2.60	2.60	1.95
kidney, adult, pool1	10017-101C8	74.70	8.11	4.71	4.31	2.70	1.30
kidney, fetal, pool1	10045-101F9	47.82	5.52	2.33	2.48	1.41	2.19
large cell lung carcinoma cell line:IA-LM	10509-107D5	55.25	6.11	1.42	0.99	0.71	1.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	19.08	4.84	0.69	0.41	1.38	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	47.16	4.22	2.94	1.83	1.47	1.83
left atrium, adult, donor1	10079-102A7	76.82	23.43	9.26	3.81	1.63	1.09
left ventricle, adult, donor1	10078-102A6	201.76	25.79	11.63	20.23	6.57	9.10
leiomyoblastoma cell line:G-402	10721-110A1	138.99	9.30	3.56	3.83	1.37	4.65
leiomyoma cell line:10964C	10569-108B2	17.24	0.00	0.00	0.00	0.00	0.72
leiomyoma cell line:15242A	10570-108B3	16.85	0.54	0.00	1.63	0.00	0.00
leiomyoma cell line:15425	10571-108B4	17.97	0.97	0.24	0.00	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	36.59	3.14	1.05	0.00	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	79.69	8.15	2.95	1.53	1.42	1.18
liposarcoma cell line:KMLS-1	10782-110G8	33.27	4.06	0.47	1.72	0.94	1.41
liposarcoma cell line:SW 872	10726-110A6	28.02	18.15	2.31	1.34	0.97	0.61
liver, adult, pool1	10018-101C9	50.89	6.64	3.89	2.92	1.13	0.81
liver, fetal, pool1	10086-102B5	69.61	5.64	1.88	0.94	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	69.56	5.40	2.04	1.31	0.29	3.35
locus coeruleus, adult, donor10252	10165-103B3	38.20	3.69	0.18	1.29	0.37	1.11
locus coeruleus, adult, donor10258	10375-105G6	62.35	8.18	1.69	3.10	0.85	1.41
locus coeruleus, newborn, donor10223	10362-105F2	16.40	0.84	0.42	0.00	0.00	1.68
lung adenocarcinoma cell line:A549	10499-107C4	24.50	2.91	0.97	0.83	1.38	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	55.15	7.58	2.76	0.69	2.07	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	26.50	6.06	0.53	0.53	0.53	0.26
lung, adult, pool1	10019-101D1	24.81	1.77	0.47	0.71	0.35	0.35
lung, fetal, donor1	10068-101I5	44.24	3.14	1.14	0.57	0.86	1.71
lung, right lower lobe, adult, donor1	10075-102A3	58.19	10.54	2.75	1.83	0.00	0.92
lymph node, adult, donor1	10077-102A5	59.17	3.79	1.42	1.42	2.84	0.47
lymphangiectasia cell line:DS-1	10727-110A7	51.95	5.48	2.85	2.63	3.51	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	62.79	14.04	5.74	3.62	4.68	1.36
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	54.37	2.55	1.70	3.40	3.40	0.85
mature adipocyte, donor1	12231-129F8	51.06	9.32	3.55	3.11	0.89	1.78
mature adipocyte, donor2	12232-129F9	35.90	5.81	2.28	1.25	0.62	2.49
mature adipocyte, donor3	12233-129G1	26.79	10.43	1.90	0.47	0.47	0.71
mature adipocyte, donor4	12234-129G2	29.74	8.95	1.58	1.32	1.58	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	105.31	4.77	2.14	2.62	5.96	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	75.58	4.51	0.00	3.38	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	50.57	10.67	0.74	1.47	0.55	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	54.32	7.94	2.22	1.59	0.95	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	17.06	2.13	0.85	0.85	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	73.41	7.59	1.52	1.35	0.51	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	48.60	11.88	1.27	1.70	0.21	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	50.08	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	31.59	2.15	1.44	1.08	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	77.23	3.24	3.89	3.24	1.30	3.89
medulla oblongata, adult, donor10252	10155-103A2	34.99	4.95	1.08	2.01	1.08	1.55
medulla oblongata, adult, pool1	10038-101F2	40.41	3.18	0.65	0.98	0.16	1.14
medulla oblongata, newborn, donor10223	10361-105F1	28.82	1.04	1.39	0.69	0.69	1.04
medulloblastoma cell line:D283 Med	10838-111E1	54.91	1.55	0.89	0.66	1.99	0.89
medulloblastoma cell line:ONS-76	10759-110E3	60.65	4.40	2.08	3.42	1.47	2.32
melanoma cell line:COLO 679	10514-107E1	79.06	6.47	4.89	8.34	4.02	2.16
melanoma cell line:G-361	10465-106H6	78.18	8.69	2.71	4.89	2.71	1.90
meningioma cell line:HKBMM	10691-109F7	18.27	2.53	0.90	0.54	0.36	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	89.88	22.03	6.17	1.76	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	52.62	4.41	0.78	1.81	0.78	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.33	2.76	1.07	0.31	0.77	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.91	2.91	0.18	0.73	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	18.63	1.24	1.24	0.83	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.85	3.93	0.28	0.28	0.84	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	10.78	2.50	0.39	0.00	0.19	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	10.41	0.00	1.39	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	12.87	0.86	0.69	0.51	0.51	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	18.06	2.88	0.58	0.23	0.12	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.77	3.05	0.53	0.80	0.66	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	18.91	2.03	0.68	0.41	0.41	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	18.92	1.56	0.57	0.85	0.43	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	15.48	0.66	0.00	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	16.19	2.91	0.42	0.28	0.42	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	16.76	0.70	0.70	0.00	0.35	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.70	1.43	0.00	0.82	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.53	1.80	0.00	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	13.03	1.24	0.00	0.31	0.21	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	11.40	0.46	0.00	0.23	0.23	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.14	1.26	0.42	0.00	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	15.24	1.20	0.30	0.30	0.15	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	15.49	2.36	1.23	0.88	0.44	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	19.14	2.21	0.00	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	17.17	0.57	0.29	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.21	3.37	0.42	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	17.81	2.74	0.00	0.46	0.91	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	15.09	2.81	0.00	0.51	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.80	2.62	0.00	0.79	0.26	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.71	1.54	0.31	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.89	0.94	0.00	0.71	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	22.00	2.37	0.00	0.00	1.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.75	1.57	0.39	0.39	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.44	2.32	0.46	0.46	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	20.19	1.73	0.29	0.29	0.58	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	17.18	0.67	0.22	0.00	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	14.66	0.96	0.00	0.24	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	26.40	2.20	0.00	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.43	1.34	0.34	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.92	2.05	0.41	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	18.47	0.43	0.43	0.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	15.26	2.60	0.97	0.32	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	1.45	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.26	2.67	0.53	0.53	0.53	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	26.17	1.64	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.21	1.17	0.78	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	4.20	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	21.86	1.99	0.00	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.79	1.19	1.19	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	3.66	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.70	2.53	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.38	2.07	0.34	0.69	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	27.94	2.15	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	3.99	0.00	0.00	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	21.60	1.63	0.41	0.41	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	18.27	0.00	2.38	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	18.28	0.00	0.59	0.00	0.59	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	24.00	1.87	0.62	0.31	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	1.34	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	30.75	3.55	1.18	0.00	2.37	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	2.57	0.00	0.00	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	35.80	3.44	0.69	0.69	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	45.03	1.48	3.46	3.96	1.98	2.97
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	47.10	2.24	4.49	1.12	6.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	49.61	3.82	2.54	6.36	1.27	5.09
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	56.42	8.87	3.63	5.24	1.61	4.84
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	78.50	2.18	4.36	6.54	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	50.68	5.07	2.53	2.53	5.07	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	41.88	4.86	6.07	2.43	2.43	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	54.23	13.56	0.00	4.52	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	48.60	11.53	4.12	1.65	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	46.43	3.37	0.99	3.97	1.39	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	32.77	5.52	1.95	3.24	0.65	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	33.61	2.04	2.04	6.11	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	30.17	4.64	1.55	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	80.79	2.60	0.47	1.42	1.18	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	88.73	1.85	2.78	3.01	1.39	4.40
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	23.74	1.95	1.23	0.82	1.03	0.31
mesothelioma cell line:Mero-25	10850-111F4	33.14	1.13	0.23	1.82	0.91	0.68
mesothelioma cell line:Mero-41	10851-111F5	24.20	2.44	0.73	0.00	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	20.81	1.33	0.89	0.44	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	43.89	3.42	2.63	2.63	1.05	0.53
mesothelioma cell line:Mero-83	10854-111F8	36.26	4.09	1.53	2.38	0.85	0.17
mesothelioma cell line:Mero-84	10855-111F9	24.52	1.01	0.51	0.76	0.51	0.51
mesothelioma cell line:Mero-95	10856-111G1	25.88	3.11	0.62	1.04	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	30.98	1.66	0.99	1.99	0.66	0.33
mesothelioma cell line:NCI-H226	10846-111E9	42.17	1.99	0.36	2.71	1.09	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	35.53	2.73	0.68	1.54	1.20	1.20
mesothelioma cell line:NCI-H28	10845-111E8	25.19	2.29	2.54	2.54	0.76	1.53
mesothelioma cell line:No36	10857-111G2	38.17	2.94	1.30	2.28	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	28.99	2.44	4.88	2.44	1.08	0.54
migratory langerhans cells, donor1	11901-125F2	18.04	0.58	0.96	0.38	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	22.35	1.34	0.49	0.49	0.37	0.24
migratory langerhans cells, donor3	11903-125F4	23.87	1.62	1.08	0.00	0.18	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	22.85	5.88	1.63	0.98	0.65	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	39.63	9.54	4.24	1.48	0.85	1.48
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	100.44	10.83	1.84	3.46	2.76	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	45.29	6.09	3.23	2.28	3.81	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	91.84	12.57	3.33	4.62	6.28	1.29
myeloma cell line:PCM6	10474-106I6	44.67	4.74	0.99	0.40	1.38	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	34.50	2.54	0.51	1.01	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	35.70	5.49	2.16	1.77	0.78	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	35.77	2.12	0.22	0.67	0.33	1.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	30.74	1.76	0.37	0.74	0.22	1.03
nasal epithelial cells, donor2	12227-129F4	40.30	0.55	0.55	1.10	0.00	1.66
neuroblastoma cell line:CHP-134	10508-107D4	80.06	6.21	1.15	2.53	2.76	1.61
neuroblastoma cell line:NB-1	10539-107G8	46.02	2.99	1.12	1.68	0.56	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	38.59	4.85	2.11	1.69	0.84	1.90
neuroblastoma cell line:NH-12	10555-107I6	48.64	2.80	1.30	2.05	2.42	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	38.91	2.85	1.42	1.66	1.42	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	59.55	3.64	1.58	2.06	1.43	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	44.28	4.23	0.20	1.21	2.82	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	98.54	13.35	3.18	3.81	5.09	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	42.32	6.65	1.33	1.06	1.06	1.60
neutrophil PMN, donor1	12133-128D9	104.12	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	76.27	14.71	4.06	1.69	1.69	1.86
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	41.63	4.80	0.80	2.40	3.20	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	31.10	2.89	0.32	0.32	1.28	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	18.13	1.58	1.05	0.53	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	50.43	5.34	1.22	1.59	0.28	0.94
occipital cortex - adult, donor10196	10172-103C1	76.23	12.36	0.00	0.00	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	47.50	11.00	2.68	1.88	1.07	0.81
occipital cortex, newborn, donor10223	10355-105E4	36.76	3.28	2.55	1.46	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	90.53	18.37	4.99	3.15	1.84	1.05
occipital lobe, fetal, donor1	10073-102A1	101.70	9.87	2.15	2.57	0.43	0.86
occipital pole, adult, pool1	10036-101E9	45.10	6.78	0.79	1.58	0.79	0.71
olfactory region, adult	10195-103E6	41.84	6.69	0.57	1.53	0.00	0.96
optic nerve, donor1	10277-104E7	46.02	6.00	0.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	16.63	2.85	1.14	0.68	1.03	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	64.71	5.77	1.24	0.82	1.24	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	31.49	3.56	1.52	0.51	1.52	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	25.76	5.66	1.16	1.73	1.27	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	30.28	3.82	0.59	0.59	1.18	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	178.46	10.28	5.61	8.41	5.61	4.67
osteosarcoma cell line:HS-Os-1	10558-107I9	22.27	2.12	0.64	1.06	0.64	1.06
ovary, adult, pool1	10020-101D2	32.32	2.27	0.70	0.79	0.52	1.14
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	39.41	4.95	0.73	1.10	0.55	0.73
pancreas, adult, donor1	10049-101G4	67.73	3.76	2.82	0.94	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	51.71	9.78	4.75	2.24	1.40	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	22.83	3.58	2.56	1.70	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.74	1.32	0.33	0.50	0.33	0.33
paracentral gyrus, adult, pool1	10035-101E8	55.55	7.60	1.19	1.28	0.46	1.46
parietal cortex, adult, donor10258	10373-105G4	45.51	4.40	1.47	2.20	0.73	2.20
parietal lobe - adult, donor10196	10171-103B9	52.67	9.40	1.88	0.00	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	49.31	13.11	1.43	1.71	0.29	1.71
parietal lobe, adult, pool1	10034-101E7	54.19	7.67	1.15	1.76	0.35	1.41
parietal lobe, fetal, donor1	10072-101I9	91.16	5.82	0.97	0.97	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	29.16	1.87	1.50	0.37	0.00	0.75
parotid gland, adult	10199-103F1	31.45	16.03	3.08	3.08	0.62	0.00
penis, adult	10200-103F2	33.84	12.89	1.07	1.07	2.15	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	24.92	0.56	0.74	0.37	0.74	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	37.88	5.97	2.33	2.19	0.73	1.46
pineal gland - adult, donor10196	10179-103C8	43.86	4.52	3.23	1.94	0.00	1.94
pineal gland, adult, donor10252	10160-103A7	64.55	8.29	0.59	1.18	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	31.98	5.02	1.25	1.88	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	55.65	3.04	1.01	1.01	1.01	3.04
pituitary gland, adult, donor10252	10162-103A9	82.87	9.90	1.04	0.52	1.04	1.04
pituitary gland, adult, donor10258	10378-105G9	51.07	5.96	0.00	0.85	0.85	1.70
placenta, adult, pool1	10021-101D3	28.60	3.98	0.43	0.43	1.08	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	45.42	7.95	3.71	1.06	1.59	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.96	2.65	0.78	0.62	2.02	0.16
pons, adult, pool1	10033-101E6	50.26	4.30	0.43	1.12	0.34	1.55
postcentral gyrus, adult, pool1	10032-101E5	53.79	7.15	1.22	1.48	0.44	1.22
promyelocytes/myelocytes PMC, donor1	12132-128D8	248.88	16.73	14.64	0.00	6.27	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	70.21	10.20	4.22	1.31	2.33	0.87
prostate cancer cell line:PC-3	10439-106E7	117.79	8.53	3.81	4.72	1.82	2.36
prostate, adult, pool1	10022-101D4	27.39	3.08	0.63	1.18	0.73	0.73
putamen, adult, donor10196	10176-103C5	52.41	8.73	1.18	1.42	0.71	0.94
putamen, adult, donor10252	10152-102I8	41.18	5.88	0.00	0.00	1.96	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	49.18	2.19	0.00	2.19	0.00	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	39.14	6.52	0.72	0.97	0.48	0.72
putamen, newborn, donor10223	10365-105F5	13.49	3.00	1.50	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	77.97	4.65	2.04	2.91	2.62	2.04
rectum, fetal, donor1	10067-101I4	111.28	16.69	5.56	5.56	2.78	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	17.81	2.76	0.64	1.27	0.85	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	36.45	1.24	0.41	0.41	0.41	1.24
retina, adult, pool1	10030-101E3	48.41	7.06	0.99	0.80	0.50	1.29
retinoblastoma cell line:Y79	10475-106I7	151.98	10.65	7.27	5.46	5.98	3.12
rhabdomyosarcoma cell line:KYM-1	10787-110H4	59.88	10.57	1.60	1.60	0.74	1.60
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	111.36	5.91	0.28	2.53	1.97	6.75
sacrococcigeal teratoma cell line:HTST	10695-109G2	26.52	3.03	0.00	0.00	2.27	0.00
salivary acinar cells, donor1	11771-123I7	36.90	5.50	1.13	1.13	1.29	0.65
salivary acinar cells, donor2	11772-123I8	28.91	5.65	1.24	0.55	1.38	0.96
salivary acinar cells, donor3	11773-123I9	43.70	11.25	3.31	1.32	1.32	0.66
salivary gland, adult, pool1	10093-102C3	35.46	8.01	1.72	0.57	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	38.02	7.76	2.78	1.52	2.19	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	44.90	8.93	2.59	1.88	2.12	1.41
seminal vesicle, adult	10201-103F3	45.50	8.47	1.06	3.17	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	56.12	0.97	1.70	1.70	0.49	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	31.45	4.03	2.01	1.76	2.77	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	30.11	2.01	0.00	2.01	1.00	6.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	23.24	3.63	1.48	0.54	1.88	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	39.13	3.98	3.09	2.43	2.43	1.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	68.38	2.58	2.84	3.61	2.45	2.58
skeletal muscle - soleus muscle, donor1	10282-104F3	118.46	43.27	11.35	8.51	1.42	2.84
skeletal muscle, adult, pool1	10023-101D5	92.95	19.19	4.56	7.68	1.80	3.48
skeletal muscle, fetal, donor1	10066-101I3	59.30	19.10	6.03	1.01	2.01	0.00
skin, adult, donor1	10074-102A2	67.85	33.93	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	65.65	10.73	1.26	3.16	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	48.36	5.00	1.67	1.33	0.67	2.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	71.87	5.99	3.47	3.47	4.10	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	58.40	6.36	1.16	1.54	0.39	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	20.44	1.15	0.33	0.66	0.82	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	45.36	1.13	0.97	0.64	2.09	2.57
small cell lung carcinoma cell line:WA-hT	10562-108A4	129.01	32.25	9.81	7.63	7.85	5.23
small intestine, adult, pool1	10024-101D6	124.70	10.27	9.91	9.79	4.42	2.99
small intestine, fetal, donor1	10064-101I1	75.18	10.81	3.19	4.18	3.44	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	21.03	3.59	1.03	0.00	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	36.96	8.53	1.81	0.78	0.26	0.78
somatostatinoma cell line:QGP-1	10781-110G7	104.53	18.23	5.36	2.41	5.09	2.41
spinal cord - adult, donor10196	10181-103D1	66.30	4.13	1.15	1.15	0.23	1.84
spinal cord, adult, donor10252	10159-103A6	33.91	2.76	0.79	2.37	0.00	2.37
spinal cord, adult, donor10258	10369-105F9	17.29	0.00	0.00	0.00	0.00	2.08
spinal cord, fetal, donor1	10056-101H2	59.76	7.32	1.83	0.61	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	18.83	0.00	0.46	0.00	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	31.96	3.88	0.75	0.90	0.90	0.60
spleen, adult, pool1	10025-101D7	30.73	3.30	0.66	0.99	0.33	0.22
spleen, fetal, pool1	10044-101F8	28.21	2.94	0.79	0.56	0.24	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	35.82	4.35	1.66	2.28	0.62	1.76
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	132.72	8.54	2.85	2.47	1.33	3.99
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	48.22	9.78	1.75	1.40	0.70	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	59.81	1.56	0.78	2.35	1.17	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	107.16	9.34	3.38	2.36	3.26	2.36
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	28.80	2.12	0.00	1.27	0.42	2.12
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	134.11	13.96	7.62	5.92	5.08	1.27
stomach, fetal, donor1	10062-101H8	136.70	50.19	12.82	6.41	2.14	4.27
submaxillary gland, adult	10202-103F4	50.70	11.96	1.14	3.99	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	28.46	2.28	0.21	1.25	0.62	2.70
substantia nigra, adult, donor10258	10371-105G2	47.59	2.07	1.55	1.03	0.52	2.59
substantia nigra, newborn, donor10223	10358-105E7	30.38	2.12	2.12	2.83	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	152.00	9.63	3.90	2.98	2.52	6.19
temporal lobe, adult, pool1	10031-101E4	51.63	6.87	0.59	1.10	0.51	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	69.09	5.70	0.71	0.71	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	40.00	2.64	1.32	0.44	0.00	1.32
tenocyte, donor1	11763-123H8	18.85	2.44	0.00	0.70	0.35	0.35
tenocyte, donor2	11765-123I1	16.02	1.91	0.38	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	12.23	2.97	0.37	0.00	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	102.32	3.91	3.40	3.06	3.57	4.59
teratocarcinoma cell line:NCR-G1	10798-110I6	55.96	3.70	1.54	1.85	2.16	1.39
teratocarcinoma cell line:PA-1	10807-111A6	80.90	4.65	2.01	0.93	3.56	1.70
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	115.78	3.55	3.17	5.59	3.17	4.19
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	65.42	0.76	0.76	2.27	2.27	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	72.64	4.58	3.27	2.51	5.13	2.62
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	99.34	2.93	1.63	2.61	2.61	1.63
testis, adult, pool1	10026-101D8	32.53	5.05	0.43	0.86	0.97	0.54
testis, adult, pool2	10096-102C6	40.15	6.32	2.26	0.90	0.90	0.90
thalamus - adult, donor10196	10168-103B6	83.90	4.42	2.21	3.31	1.10	1.10
thalamus, adult, donor10252	10154-103A1	30.01	3.13	0.78	1.56	0.16	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	52.35	0.00	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	59.95	5.76	1.48	2.96	0.16	1.32
thalamus, newborn, donor10223	10366-105F6	34.52	2.88	1.15	1.73	0.58	0.00
throat, adult	10209-103G2	46.44	18.73	7.49	3.00	1.25	0.50
throat, fetal, donor1	10061-101H7	83.49	15.54	3.05	4.57	1.22	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	94.60	5.37	2.38	2.58	0.79	0.79
thymus, adult, pool1	10027-101D9	38.27	1.89	0.70	0.99	1.29	0.60
thymus, fetal, pool1	10043-101F7	31.59	1.35	0.31	0.94	1.04	1.14
thyroid carcinoma cell line:KHM-5M	10776-110G2	35.37	5.32	1.86	1.99	0.93	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	57.83	6.01	1.26	2.10	2.10	0.70
thyroid, adult, pool1	10028-101E1	43.58	5.88	1.87	2.15	1.68	0.75
thyroid, fetal, donor1	10060-101H6	109.42	24.26	5.27	6.33	2.64	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	95.47	36.96	9.24	3.08	6.16	3.08
tongue, adult	10203-103F5	49.31	16.28	2.79	3.49	0.47	1.16
tongue, fetal, donor1	10059-101H5	104.04	32.71	11.03	11.43	3.55	3.55
tonsil, adult, pool1	10047-101G2	47.98	6.61	1.80	1.40	1.90	1.00
trachea, adult, pool1	10029-101E2	26.01	2.54	0.57	1.15	0.16	0.74
trachea, fetal, donor1	10058-101H4	62.71	18.47	3.46	3.46	2.31	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	39.68	4.25	0.71	0.71	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	35.36	3.34	1.22	1.42	1.22	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	128.48	8.77	3.29	3.13	5.48	2.04
tridermal teratoma cell line:HGRT	10694-109G1	34.25	5.71	3.81	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	27.17	2.54	0.85	0.59	0.42	1.02
umbilical cord, fetal, donor1	10057-101H3	81.37	8.35	2.09	0.00	2.09	2.09
uterus, adult, pool1	10100-102D1	37.20	1.54	0.68	1.02	0.51	1.02
uterus, fetal, donor1	10055-101H1	51.70	10.24	2.56	1.54	1.54	1.02
vagina, adult	10204-103F6	12.28	2.58	0.00	0.65	0.65	0.00
vein, adult	10191-103E2	28.93	4.60	1.10	1.10	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	21.90	5.07	2.67	1.07	2.40	0.80